{"meta":{"query_hash":"bc6c5d71f5d0","filters":{"venue":"Drugs of today"},"cohort_total":57,"direct_labels_cover":0,"predictions_cover":57,"exported":57,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/bc6c5d71f5d0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs+of+today"},"results":[{"id":"W183877133","doi":"10.1358/dot.2012.48.12.1885866","title":"Remestemcel-L, the first cellular therapy product for the treatmentof graft-versus-host disease","year":2012,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Mesenchymal stem cell; Graft-versus-host disease; Disease; Transplantation; Cell therapy; Front line; Stem cell; Immunology; Surgery; Internal medicine; Pathology","score_opus":0.07970850809014411,"score_gpt":0.3356937943612554,"score_spread":0.2559852862711113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W183877133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006618323,0.9970577,0.0001906375,0.00013276127,0.00010178451,0.000009317065,0.000034883313,0.000015372747,0.0017958703],"genre_scores_gemma":[0.003543928,0.99393976,0.00040120984,0.00019223879,0.00008157278,0.000013020825,0.00008838022,0.0000032221826,0.0017366706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998816,0.000017111028,0.000015851681,0.00002105899,0.000053088872,0.000011348899],"domain_scores_gemma":[0.9999001,0.00003709526,0.000023697892,0.0000038652156,0.000022630335,0.000012518724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021978817,0.0006788287,0.0008556638,0.0017106117,0.0001992572,0.00050371885,0.0005820315,0.00057142595,0.003385998],"category_scores_gemma":[0.00025214467,0.0001452908,0.00034018408,0.0012330238,0.00027562815,0.00073645136,0.000400445,0.0009645118,0.0022118452],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000877758,0.00008690928,0.00016058188,0.0072716046,0.000050766736,0.0002443431,0.000033256667,0.00014975232,0.0050944756,0.000906212,0.008035898,0.97787833],"study_design_scores_gemma":[0.000035036384,0.00022438933,0.0012508356,0.0013808565,0.000109479675,0.0036460073,0.000036980466,0.0000666881,0.004015545,0.00047491264,0.9887394,0.000019927673],"about_ca_topic_score_codex":0.00056366355,"about_ca_topic_score_gemma":0.0012310704,"teacher_disagreement_score":0.003385998,"about_ca_system_score_codex":0.00033657558,"about_ca_system_score_gemma":0.00049810624,"threshold_uncertainty_score":0.011327267},"labels":[],"label_agreement":null},{"id":"W1968779439","doi":"10.1358/dot.2005.41.4.908565","title":"Statin-associated neuromyotoxicity","year":2005,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Geranylgeranyl pyrophosphate; Myopathy; Rhabdomyolysis; Statin; Mevalonate pathway; Disease; Bioinformatics; Internal medicine; Prenylation; Biochemistry; Biology","score_opus":0.010485788395464093,"score_gpt":0.259453654406713,"score_spread":0.24896786601124887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968779439","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8399438,0.10943335,0.0021497996,0.004858505,0.00029377788,0.0002341431,0.00095455744,0.00020066895,0.041931342],"genre_scores_gemma":[0.96780306,0.024536729,0.00066858565,0.001898767,0.00025428415,0.000036296344,0.00028274592,0.000014300192,0.004505232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975854,0.000047472146,0.000043310163,0.000033397006,0.00006243906,0.000054873115],"domain_scores_gemma":[0.9996037,0.000048043166,0.00019284719,0.000035035813,0.000053416716,0.000067105204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023513603,0.00025699983,0.00029502827,0.00040460582,0.00044172365,0.00030872723,0.00015536678,0.00058823975,0.0033193377],"category_scores_gemma":[0.0007920061,0.000095571624,0.00027942794,0.0004776585,0.0002631846,0.0002088801,0.00052533037,0.00042973168,0.0008992459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026632457,0.00030101827,0.2823301,0.0018551557,0.0005290032,0.19457336,0.0005216394,0.0004846363,0.047474854,0.0044024345,0.010773509,0.45409104],"study_design_scores_gemma":[0.00014520514,0.0011567455,0.45997357,0.0007023889,0.00036324144,0.4452438,0.00038169543,0.00090603274,0.01118671,0.0035589621,0.076327264,0.000054383218],"about_ca_topic_score_codex":0.0015982251,"about_ca_topic_score_gemma":0.002471606,"teacher_disagreement_score":0.0033193377,"about_ca_system_score_codex":0.0005194158,"about_ca_system_score_gemma":0.00046603061,"threshold_uncertainty_score":0.011104226},"labels":[],"label_agreement":null},{"id":"W1988535187","doi":"10.1358/dot.2009.45.10.1417873","title":"Degarelix for the treatment of prostate cancer","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Testosterone (patch); Castration; Androgen deprivation therapy; Gonadotropin-releasing hormone; Hormone antagonist; Prostate; Management of prostate cancer; Orchiectomy; Hormone; Internal medicine; Urology; Oncology; Cancer; Endocrine system; Luteinizing hormone","score_opus":0.06837846130566895,"score_gpt":0.4177318112487104,"score_spread":0.34935334994304146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988535187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019311158,0.9971506,0.00011515108,0.00013157666,0.00014327941,0.000009407428,0.000026370803,0.000013993011,0.0022165333],"genre_scores_gemma":[0.0015529054,0.9953407,0.00026810428,0.000272739,0.00019927941,0.000009381205,0.00008634466,0.0000032661956,0.0022673418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998698,0.000018424533,0.000014332056,0.000027650643,0.00005633371,0.000013455569],"domain_scores_gemma":[0.99989295,0.000040717496,0.000028457018,0.0000037937118,0.000018844436,0.00001521818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027450177,0.000856433,0.00094844826,0.0025635068,0.00028875645,0.00054852944,0.000605981,0.00058178155,0.009069661],"category_scores_gemma":[0.00028881262,0.00018214574,0.000482329,0.0021659394,0.00029275005,0.00080444844,0.0004782977,0.0016018243,0.004884439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010183621,0.0000951246,0.00015446401,0.009010065,0.000088920504,0.00028121122,0.00004408989,0.00019240452,0.002413336,0.0015066171,0.031686205,0.9544257],"study_design_scores_gemma":[0.00005222217,0.00012034254,0.0009865707,0.0018719153,0.00010869948,0.0029013217,0.000032200434,0.000054064098,0.0006225328,0.0010800504,0.9921556,0.000014613178],"about_ca_topic_score_codex":0.001013138,"about_ca_topic_score_gemma":0.002013586,"teacher_disagreement_score":0.009069661,"about_ca_system_score_codex":0.0003197369,"about_ca_system_score_gemma":0.00046717082,"threshold_uncertainty_score":0.03034103},"labels":[],"label_agreement":null},{"id":"W1995684830","doi":"10.1358/dot.2006.42.3.957358","title":"Clinical experience with erlotinib in non-small-cell lung cancer(NSCLC)","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Epidermal growth factor receptor; Erlotinib Hydrochloride; Oncology; Tyrosine kinase; EGFR inhibitors; Cancer research; Cancer; T790M; Tyrosine-kinase inhibitor; Clinical trial; Internal medicine; Pharmacology; Gefitinib; Receptor","score_opus":0.03141548310013683,"score_gpt":0.41588384948687834,"score_spread":0.38446836638674153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995684830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29749164,0.6627792,0.0025240534,0.0070545063,0.0015475589,0.00026064526,0.00085764134,0.00013542928,0.027349308],"genre_scores_gemma":[0.6515679,0.32172918,0.0022877525,0.006936184,0.0017271151,0.00018613304,0.0025519142,0.00006859504,0.012945319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996983,0.00010043021,0.000041757638,0.000050060684,0.00006923894,0.000040269602],"domain_scores_gemma":[0.9996642,0.000107158325,0.000049046244,0.000021459151,0.00005552296,0.000102609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093781255,0.00043792158,0.0006613116,0.0002588308,0.00036959015,0.00053670903,0.00032168883,0.00052260375,0.0020048479],"category_scores_gemma":[0.0013155106,0.0000863233,0.00054324593,0.0005766906,0.00017775226,0.0005396249,0.00036048127,0.0013065378,0.0012393296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034892648,0.001386811,0.011969399,0.0017493115,0.0004359554,0.0026878305,0.0004755029,0.00047761985,0.008764334,0.00064206636,0.020313295,0.94760865],"study_design_scores_gemma":[0.0050371597,0.03713548,0.13495362,0.00243761,0.0019163734,0.05400372,0.0005445863,0.0015639829,0.018937634,0.0013170156,0.7420037,0.00014914622],"about_ca_topic_score_codex":0.0004586868,"about_ca_topic_score_gemma":0.0009987525,"teacher_disagreement_score":0.0020048479,"about_ca_system_score_codex":0.00038612416,"about_ca_system_score_gemma":0.00036435534,"threshold_uncertainty_score":0.006706953},"labels":[],"label_agreement":null},{"id":"W2002072862","doi":"10.1358/dot.2006.42.9.996568","title":"Ropinirole treatment for restless legs syndrome","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ropinirole; Restless legs syndrome; Medicine; Selegiline; Levodopa; Pramipexole; Placebo; Dopaminergic; Rotigotine; Population; Dopamine agonist; Dopamine; Pharmacology; Internal medicine; Parkinson's disease; Insomnia; Alternative medicine; Disease","score_opus":0.11435771493024179,"score_gpt":0.43399652833237107,"score_spread":0.3196388134021293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002072862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026686286,0.99872905,0.00005404571,0.00009926157,0.00010436009,0.0000070651395,0.0000067466967,0.0000062446393,0.0007264584],"genre_scores_gemma":[0.0020539586,0.99660033,0.00016300647,0.0001826481,0.00018103704,0.000014286417,0.00002446283,0.0000016539747,0.00077875727],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99988174,0.00002913342,0.000018982842,0.000021346403,0.00003668252,0.000012101342],"domain_scores_gemma":[0.9998678,0.00006770335,0.000032939795,0.0000035664518,0.000016671262,0.0000113162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032176124,0.0007192426,0.0012727415,0.002171155,0.00027975318,0.00044563625,0.0005641954,0.0008972372,0.0044079344],"category_scores_gemma":[0.00035712108,0.00016405963,0.00049956597,0.0014795448,0.00022851714,0.00073810143,0.0002902671,0.0008298612,0.0013914123],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001818717,0.00011127481,0.00018505032,0.017940186,0.000109494285,0.00057281245,0.00007027229,0.00016910922,0.0015859343,0.0007637507,0.014847717,0.96346265],"study_design_scores_gemma":[0.00025491806,0.000688902,0.003857188,0.008788389,0.00053774426,0.010955079,0.00017552254,0.00022201189,0.001995897,0.0012500698,0.97123766,0.000036487774],"about_ca_topic_score_codex":0.0005408806,"about_ca_topic_score_gemma":0.0012043937,"teacher_disagreement_score":0.0044079344,"about_ca_system_score_codex":0.00027930757,"about_ca_system_score_gemma":0.00042094887,"threshold_uncertainty_score":0.01474601},"labels":[],"label_agreement":null},{"id":"W2003316205","doi":"10.1358/dot.2010.46.2.1464700","title":"Saxagliptin in type 2 diabetes","year":2010,"lang":"en","type":"article","venue":"Drugs of today","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Saxagliptin; Medicine; Glycemic; Metformin; Incretin; Type 2 diabetes; Hypoglycemia; Pharmacology; Diabetes mellitus; Internal medicine; Sitagliptin; Endocrinology","score_opus":0.006862667400269849,"score_gpt":0.24396767172015393,"score_spread":0.23710500431988407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003316205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042103026,0.91833264,0.0015902,0.017788997,0.0066975174,0.000039410144,0.00017563369,0.00008035461,0.051084835],"genre_scores_gemma":[0.038925875,0.88885736,0.0033017003,0.02069163,0.013370765,0.00011444193,0.0006229596,0.000028783417,0.03408656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998173,0.0000549917,0.000019877527,0.000020841722,0.00006656998,0.000020399992],"domain_scores_gemma":[0.99974304,0.00009703776,0.000036856713,0.000013631328,0.000048690872,0.000060711533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006579126,0.00040814196,0.0006673943,0.00047029532,0.000221221,0.0005115687,0.00023893756,0.0011486723,0.0069986735],"category_scores_gemma":[0.0007600489,0.00008224064,0.00026426304,0.00063750194,0.0002631633,0.00042811251,0.00048080937,0.0021449418,0.0043808725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075875846,0.00021663359,0.0009031458,0.0012429772,0.000055405882,0.00086195266,0.00006648897,0.00025667992,0.0013999541,0.011659427,0.11322759,0.86935085],"study_design_scores_gemma":[0.00041479935,0.00052792655,0.0032763267,0.001033945,0.000103373255,0.0029427314,0.000033321732,0.00024581733,0.0005211178,0.007666869,0.9832202,0.000013555806],"about_ca_topic_score_codex":0.00054336427,"about_ca_topic_score_gemma":0.0008638469,"teacher_disagreement_score":0.0069986735,"about_ca_system_score_codex":0.0003325542,"about_ca_system_score_gemma":0.000603042,"threshold_uncertainty_score":0.023412943},"labels":[],"label_agreement":null},{"id":"W2020779524","doi":"10.1358/dot.2004.40.10.863742","title":"Gefitinib: Current status in the treatment of non-small cell lungcancer","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Internal medicine; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Adverse effect","score_opus":0.03334470967723603,"score_gpt":0.38308849286908947,"score_spread":0.34974378319185345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020779524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009040925,0.9906872,0.00038398345,0.0040249215,0.0011030217,0.00001996198,0.00008128887,0.00008409118,0.0027114167],"genre_scores_gemma":[0.012232791,0.97633207,0.0010914104,0.002857677,0.0033029213,0.000069943846,0.0004947014,0.000030384756,0.0035881433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939585,0.00011192679,0.00010143402,0.00011144663,0.00016774087,0.000111582965],"domain_scores_gemma":[0.9980166,0.00045793314,0.00032067453,0.000050429004,0.0005525024,0.0006018815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002615502,0.0009465958,0.0017185492,0.0011962309,0.0005173967,0.0023827178,0.0011142158,0.0023215616,0.0073372326],"category_scores_gemma":[0.0022154779,0.00026810632,0.0005708702,0.0021242101,0.0010470892,0.0034060178,0.0009776973,0.0025224546,0.0047211177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050232786,0.00013282867,0.0005699021,0.0031821653,0.000043202595,0.000104140854,0.000049945982,0.00022534962,0.0011361216,0.001799831,0.047277167,0.9449771],"study_design_scores_gemma":[0.00014880329,0.0008169988,0.0019627833,0.0014415256,0.00012642075,0.0007358416,0.000052770414,0.000467894,0.0006719731,0.0012251938,0.9923183,0.000031672258],"about_ca_topic_score_codex":0.001067917,"about_ca_topic_score_gemma":0.0021117928,"teacher_disagreement_score":0.0073372326,"about_ca_system_score_codex":0.0012584355,"about_ca_system_score_gemma":0.0026004468,"threshold_uncertainty_score":0.02454555},"labels":[],"label_agreement":null},{"id":"W2029669980","doi":"10.1358/dot.2009.45.1.1315920","title":"Strategies to preserve prostate health","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Prostatitis; Prostate Diseases; Clinical trial; Prostate; Etiology; Prostate disease; Intensive care medicine; Bioinformatics; Cancer; Pathology; Internal medicine","score_opus":0.045376115858439495,"score_gpt":0.3922815173844368,"score_spread":0.3469054015259973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029669980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014733312,0.9958835,0.00039638727,0.00078190886,0.00029860734,0.00001283123,0.0000236869,0.000019590982,0.0024361592],"genre_scores_gemma":[0.0011042817,0.9961849,0.00074384856,0.00063419715,0.00017213135,0.000016576309,0.000042892956,0.00000265574,0.0010984901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997595,0.00005817907,0.000031271928,0.000038775765,0.000086390035,0.000025946614],"domain_scores_gemma":[0.99979955,0.00008863672,0.000038662845,0.000012788231,0.000041770152,0.000018688323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005467304,0.0010291575,0.0013571111,0.0022375325,0.00035383223,0.0008500532,0.00088021404,0.0014653011,0.0064036027],"category_scores_gemma":[0.0006731251,0.00026583357,0.00063728023,0.0012650646,0.00053989654,0.0014510945,0.0007327491,0.0020823039,0.0031671696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005630194,0.00014334201,0.00017776179,0.021925155,0.00018091948,0.0002467477,0.00010380626,0.00035974474,0.0026967262,0.008896571,0.030406054,0.93480694],"study_design_scores_gemma":[0.000028620787,0.000092318754,0.00091588835,0.006077963,0.000121420635,0.0014029846,0.00009769009,0.000054386728,0.00064120366,0.0031484177,0.9874028,0.000016345655],"about_ca_topic_score_codex":0.0010719565,"about_ca_topic_score_gemma":0.0024044127,"teacher_disagreement_score":0.0064036027,"about_ca_system_score_codex":0.0005088935,"about_ca_system_score_gemma":0.0011709995,"threshold_uncertainty_score":0.021422148},"labels":[],"label_agreement":null},{"id":"W2038264909","doi":"10.1358/dot.2003.39.8.799407","title":"Role of 5-HT receptors in treatment of overactive bladder","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Serotonergic; Overactive bladder; Urination; Reflex; Duloxetine; Urology; Urinary bladder; Urethral sphincter; Receptor; Internal medicine; Endocrinology; Pharmacology; Serotonin; Urethra; Urinary system; Pathology","score_opus":0.040580010735959814,"score_gpt":0.37369519770281967,"score_spread":0.3331151869668599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038264909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015683005,0.9987092,0.00006158779,0.00010423737,0.00008198164,0.000005040702,0.000010992751,0.00000607338,0.00086401106],"genre_scores_gemma":[0.0009121933,0.9981902,0.00014472131,0.00009625305,0.00006720661,0.0000071376853,0.000020117786,9.623947e-7,0.0005612341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998803,0.000026052307,0.000016153645,0.000018725657,0.000046723537,0.000012003006],"domain_scores_gemma":[0.99986374,0.000066720655,0.000023535076,0.000004476289,0.000028024446,0.000013606944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039931323,0.0006659228,0.0012485619,0.002105539,0.00024493705,0.0005133895,0.0008903578,0.00088255084,0.004642875],"category_scores_gemma":[0.0003566174,0.00018193501,0.00040316107,0.0018731208,0.0003157751,0.000655334,0.00034574053,0.0010702871,0.0020649838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010419799,0.000107007865,0.00016733314,0.011733947,0.000088278925,0.00041184234,0.00005760053,0.00032041722,0.0015308703,0.0012646602,0.01467788,0.969536],"study_design_scores_gemma":[0.00007338946,0.00025203812,0.0026025204,0.0049509415,0.00020623454,0.0032216897,0.00011268016,0.00015734344,0.00085922173,0.0016169968,0.985927,0.00001991187],"about_ca_topic_score_codex":0.00156501,"about_ca_topic_score_gemma":0.003582889,"teacher_disagreement_score":0.004642875,"about_ca_system_score_codex":0.00044344668,"about_ca_system_score_gemma":0.00060731516,"threshold_uncertainty_score":0.015531957},"labels":[],"label_agreement":null},{"id":"W2041935038","doi":"10.1358/dot.2008.44.7.1227147","title":"Desvenlafaxine succinate for major depressive disorder","year":2008,"lang":"en","type":"review","venue":"Drugs of today","topic":"Treatment of Major Depression","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Venlafaxine; Internal medicine; Adverse effect; Pharmacology; Antidepressant; Vasomotor; Endocrinology","score_opus":0.027669575657758242,"score_gpt":0.3371435443253235,"score_spread":0.30947396866756527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041935038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2748618,0.49902147,0.008189419,0.04182453,0.0051787877,0.0022911273,0.005184085,0.0013127554,0.16213599],"genre_scores_gemma":[0.7503863,0.13758212,0.008551138,0.02982763,0.0020011584,0.0011206581,0.0054160925,0.00008917891,0.065025814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985194,0.00004534232,0.000027301961,0.0000184579,0.00003201743,0.000024920126],"domain_scores_gemma":[0.999811,0.00004510615,0.00004617612,0.000008220795,0.000036752335,0.000052824078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034466566,0.000289781,0.0004943016,0.00020243516,0.0002675277,0.0002973639,0.00028164123,0.0006005418,0.011106871],"category_scores_gemma":[0.000781502,0.00006896303,0.0006054475,0.000186351,0.0001284899,0.00021818632,0.00023682081,0.00090452994,0.003221259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008947888,0.0012034134,0.0066861655,0.0030222216,0.00062263745,0.0018881907,0.00010103851,0.00025904094,0.017370846,0.001708769,0.112409905,0.8457799],"study_design_scores_gemma":[0.020978509,0.014270165,0.10789631,0.0025412,0.00095047505,0.016670927,0.00023680659,0.0012258652,0.010294748,0.0037242672,0.82111734,0.00009337598],"about_ca_topic_score_codex":0.0007574777,"about_ca_topic_score_gemma":0.003650256,"teacher_disagreement_score":0.011106871,"about_ca_system_score_codex":0.00056989834,"about_ca_system_score_gemma":0.00034314033,"threshold_uncertainty_score":0.037156224},"labels":[],"label_agreement":null},{"id":"W2045159955","doi":"10.1358/dot.2004.40.5.850489","title":"Levocetirizine: A new selective H1 receptor antagonist for use inallergic disorders","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Levocetirizine; Cetirizine; Medicine; Pharmacology; Histamine; Histamine H1 receptor; Antagonist; Pharmacokinetics; Receptor; Internal medicine","score_opus":0.03495536806048386,"score_gpt":0.3191909200766362,"score_spread":0.2842355520161523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045159955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035438337,0.99802125,0.000142438,0.00012856536,0.00008583711,0.0000075638773,0.00002391295,0.000015987916,0.0012199861],"genre_scores_gemma":[0.0016910895,0.9964959,0.00022928747,0.00012907277,0.00008185592,0.000007811203,0.00006311169,0.0000018029187,0.0012999872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999163,0.000010382732,0.000011562446,0.000017241176,0.000034631925,0.000009826032],"domain_scores_gemma":[0.99991965,0.000023698538,0.00001781882,0.0000025641082,0.000022508691,0.000013830646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023432274,0.0007735706,0.0011703996,0.0021509114,0.00026113554,0.00063323975,0.0006902355,0.0006704045,0.0041953237],"category_scores_gemma":[0.00024307985,0.00017921104,0.00031772317,0.0021343376,0.00026978584,0.00081161916,0.00035869968,0.0009620878,0.0025342228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009828827,0.00008968917,0.00017344055,0.01044514,0.00007783017,0.00040249852,0.000048008802,0.00019854435,0.003042997,0.000682248,0.017081857,0.9676595],"study_design_scores_gemma":[0.00005710775,0.00014834039,0.0016029155,0.0013009303,0.00015409714,0.0035432626,0.00005859118,0.00008621286,0.0010937216,0.0005411098,0.991398,0.000015684933],"about_ca_topic_score_codex":0.0012085214,"about_ca_topic_score_gemma":0.0025776646,"teacher_disagreement_score":0.0041953237,"about_ca_system_score_codex":0.00038571778,"about_ca_system_score_gemma":0.0005109147,"threshold_uncertainty_score":0.014034808},"labels":[],"label_agreement":null},{"id":"W2053823757","doi":"10.1358/dot.2002.38.10.740195","title":"Identification of parkinsonism and Parkinson's disease","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Glenrose Rehabilitation Hospital","funders":"","keywords":"Parkinsonism; Medicine; Progressive supranuclear palsy; Parkinson's disease; Disease; Magnetic resonance imaging; Neuroimaging; Dopaminergic; Movement disorders; Physical medicine and rehabilitation; Psychiatry; Pathology; Radiology; Internal medicine; Dopamine","score_opus":0.027922660074428625,"score_gpt":0.3044069923022708,"score_spread":0.2764843322278422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053823757","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6230847,0.15522692,0.028018167,0.013495747,0.0021160806,0.0026856125,0.005932621,0.00073439506,0.16870573],"genre_scores_gemma":[0.87249976,0.050771892,0.042044204,0.0034990683,0.00078140915,0.0008054444,0.00363385,0.00005983731,0.025904568],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982589,0.0004718029,0.00021783252,0.00019219822,0.00072880153,0.00013056576],"domain_scores_gemma":[0.99881136,0.00022975274,0.00026996102,0.00004452219,0.0004914113,0.00015308599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012411654,0.0006152815,0.0009461945,0.003098069,0.0006933599,0.00085777807,0.00058490236,0.0009804248,0.00319644],"category_scores_gemma":[0.0032716184,0.00018881689,0.00033439905,0.0016917975,0.00035137328,0.0009784731,0.0012312563,0.0010102474,0.0013524359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076012814,0.00065069867,0.5104109,0.0020260923,0.00017678364,0.0077538462,0.0020670488,0.00033443168,0.009673848,0.0036651702,0.031112105,0.431369],"study_design_scores_gemma":[0.000092641116,0.0011428109,0.7566603,0.0022882207,0.00026607348,0.051572017,0.0036115625,0.0015129595,0.007377976,0.0048123547,0.17049101,0.0001720526],"about_ca_topic_score_codex":0.003010777,"about_ca_topic_score_gemma":0.004749575,"teacher_disagreement_score":0.00319644,"about_ca_system_score_codex":0.0005851692,"about_ca_system_score_gemma":0.0008827956,"threshold_uncertainty_score":0.0106931925},"labels":[],"label_agreement":null},{"id":"W2064695702","doi":"10.1358/dot.2002.38.1.677133","title":"Medical backgrounder on varicocele","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Sperm and Testicular Function","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Varicocele; Medicine; Hydrocele; Male infertility; Semen quality; Infertility; Urology; Semen; Surgery; Andrology; Pregnancy; Biology","score_opus":0.05104752085932522,"score_gpt":0.329940138467689,"score_spread":0.27889261760836376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064695702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002811825,0.9764331,0.00016089201,0.0012041363,0.0035780063,0.000018633878,0.00008409627,0.00003115449,0.018208815],"genre_scores_gemma":[0.002343571,0.9728852,0.00028555002,0.0018050235,0.0034184516,0.000018674244,0.0002041828,0.000008329414,0.019031055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997739,0.00003753015,0.00003147554,0.00004310328,0.00008784996,0.00002618553],"domain_scores_gemma":[0.99962664,0.00012335337,0.00006686477,0.000019080642,0.000112934904,0.000051146857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027164264,0.0009909978,0.0011010598,0.0025339082,0.00044712637,0.00081066106,0.0008542601,0.0011468225,0.034795333],"category_scores_gemma":[0.0011125167,0.00019525106,0.00038387722,0.0033555685,0.00040193327,0.001376243,0.00065053656,0.0011403537,0.022721145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008053511,0.00006816172,0.0003413681,0.008108404,0.000036821093,0.00078185776,0.0000649775,0.00014101256,0.0008513341,0.0015437094,0.1880751,0.7999066],"study_design_scores_gemma":[0.000010936799,0.000032256885,0.0008864564,0.0020677962,0.000026362277,0.0022157447,0.000025476715,0.000022085782,0.00013334656,0.00039902332,0.9941737,0.0000067823157],"about_ca_topic_score_codex":0.00141481,"about_ca_topic_score_gemma":0.002010785,"teacher_disagreement_score":0.034795333,"about_ca_system_score_codex":0.00048360633,"about_ca_system_score_gemma":0.0011396436,"threshold_uncertainty_score":0.11640203},"labels":[],"label_agreement":null},{"id":"W2079795343","doi":"10.1358/dot.2011.47.5.1584113","title":"Psychosis in Parkinson's disease: Therapeutic options","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Quetiapine; Ziprasidone; Medicine; Psychosis; Clozapine; Olanzapine; Risperidone; Rivastigmine; Parkinson's disease; Psychiatry; Donepezil; Antipsychotic; Amantadine; Amisulpride; Disease; Schizophrenia (object-oriented programming); Intensive care medicine; Dementia; Pharmacology; Internal medicine","score_opus":0.051478196202870315,"score_gpt":0.3382877219087331,"score_spread":0.28680952570586277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079795343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043292905,0.9991934,0.000027923677,0.00013421386,0.00006129267,0.0000022713712,0.000004304964,0.0000024361839,0.00053090515],"genre_scores_gemma":[0.00049864507,0.9989299,0.000082309634,0.00012800825,0.000095040596,0.0000033024164,0.0000083346895,5.684563e-7,0.00025373834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997528,0.0000559966,0.000047609978,0.00002995276,0.00009625563,0.000017403278],"domain_scores_gemma":[0.9997156,0.00015070684,0.00005756112,0.000009710197,0.000044171622,0.000022195853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004899923,0.0009650321,0.0017699508,0.0027783741,0.00026769203,0.0008786793,0.0005609326,0.0008566611,0.0052456222],"category_scores_gemma":[0.0006395062,0.000255192,0.0006110295,0.0026729717,0.00044190706,0.0012098178,0.0005646642,0.0013402107,0.0014000928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008333369,0.00007220422,0.00012468146,0.04174679,0.00014290247,0.00036211035,0.000092025395,0.000284693,0.0008398688,0.0028779407,0.02319472,0.93017876],"study_design_scores_gemma":[0.0000685776,0.00013090095,0.0015652544,0.019991621,0.000291735,0.003913745,0.00016402428,0.00009544858,0.00023911799,0.003771925,0.9697436,0.00002405632],"about_ca_topic_score_codex":0.0012641756,"about_ca_topic_score_gemma":0.0034744611,"teacher_disagreement_score":0.0052456222,"about_ca_system_score_codex":0.00059261644,"about_ca_system_score_gemma":0.0010352333,"threshold_uncertainty_score":0.017548382},"labels":[],"label_agreement":null},{"id":"W2117178293","doi":"10.1358/dot.2004.40.11.872578","title":"Efalizumab: Advancing psoriasis management with a novel, targetedT-cell modulator","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Psoriasis; Medicine; Pathogenesis; Monoclonal antibody; Immunology; Clinical trial; Monoclonal; Dermatology; Antibody; Plaque psoriasis; Pathology","score_opus":0.013235696228063943,"score_gpt":0.24904233892696076,"score_spread":0.2358066426988968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117178293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024262075,0.9978707,0.00027207474,0.00036495886,0.00019980919,0.000007343944,0.000009471062,0.000014552774,0.0010184973],"genre_scores_gemma":[0.0011475745,0.9964684,0.0005823078,0.00030727265,0.00022882242,0.000009984377,0.00002273289,0.0000022830036,0.0012305474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998031,0.000031343698,0.000024934387,0.000030207748,0.000089659035,0.000020782223],"domain_scores_gemma":[0.9998778,0.00003625166,0.00002720043,0.000005238499,0.00003406948,0.000019428373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005817658,0.000921219,0.0012434864,0.0021898502,0.0002842094,0.00096928596,0.0007883331,0.001359063,0.003223264],"category_scores_gemma":[0.00033022228,0.0002549634,0.00045010098,0.0019305779,0.00036012335,0.0013143909,0.0005995078,0.0018346703,0.0029096552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085053005,0.00010429293,0.00012600828,0.004897981,0.000047572834,0.00037509756,0.00003871334,0.00029024432,0.004205048,0.0021103837,0.01671439,0.9710053],"study_design_scores_gemma":[0.00006678345,0.00015856916,0.0009542983,0.0015783741,0.00005726767,0.0036452492,0.000043691434,0.00016178396,0.0011506145,0.0013596779,0.9908075,0.000016083823],"about_ca_topic_score_codex":0.0008749328,"about_ca_topic_score_gemma":0.0019087882,"teacher_disagreement_score":0.003223264,"about_ca_system_score_codex":0.00075746723,"about_ca_system_score_gemma":0.0006887521,"threshold_uncertainty_score":0.0107828975},"labels":[],"label_agreement":null},{"id":"W2317463698","doi":"10.1358/dot.2000.36.2-3.568786","title":"Sildenafil citrate (Viagra(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Sildenafil; Medicine; Cyclic guanosine monophosphate; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Pharmacology; Erectile function; Phosphodiesterase; Phosphodiesterase inhibitor; Internal medicine; Urology; Biochemistry; Enzyme","score_opus":0.013805522544178545,"score_gpt":0.2656979121947541,"score_spread":0.25189238965057553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317463698","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6642454,0.15691814,0.015528445,0.0035643505,0.0033940522,0.0024263288,0.009961923,0.005405918,0.13855542],"genre_scores_gemma":[0.86319804,0.04476936,0.011583246,0.0023231592,0.0017759817,0.000565414,0.006161536,0.00017454912,0.06944864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998325,0.000024395413,0.0000127991225,0.000055044376,0.000050312374,0.000024999574],"domain_scores_gemma":[0.9999176,0.000009885597,0.000018855957,0.0000104522505,0.000010029406,0.000033158092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012625912,0.00042903196,0.00050672406,0.0005510692,0.00025151463,0.00041412402,0.00033459425,0.00072427024,0.018076321],"category_scores_gemma":[0.0003077158,0.000109902765,0.00025870473,0.00036961288,0.00023645393,0.0002602348,0.00033332518,0.0006620911,0.008090259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067119496,0.0020478822,0.0030096925,0.0016674827,0.00016527138,0.0016798255,0.00015075582,0.00030913207,0.36977485,0.0032650451,0.025398254,0.5858199],"study_design_scores_gemma":[0.004471288,0.03559154,0.026590608,0.00029717802,0.0006260889,0.018195005,0.00009147578,0.0013732633,0.24023113,0.00084237894,0.6716176,0.00007241556],"about_ca_topic_score_codex":0.00044071695,"about_ca_topic_score_gemma":0.00065073866,"teacher_disagreement_score":0.018076321,"about_ca_system_score_codex":0.0001811771,"about_ca_system_score_gemma":0.00038058156,"threshold_uncertainty_score":0.060471356},"labels":[],"label_agreement":null},{"id":"W2321447119","doi":"10.1358/dot.2011.47.6.1603439","title":"Tesamorelin: A novel therapeutic option for HIV/HAART-associatedincreased visceral adipose tissue","year":2011,"lang":"en","type":"article","venue":"Drugs of today","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Adipose tissue; Hormone; Glucose homeostasis; Endocrinology; Internal medicine; Homeostasis; Lipid profile; Obesity; Bioinformatics; Diabetes mellitus; Insulin resistance; Biology","score_opus":0.037363104453776066,"score_gpt":0.3154414242656713,"score_spread":0.27807831981189524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321447119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76940095,0.18247257,0.010282563,0.0044944393,0.0011655431,0.00030325286,0.0005673898,0.00039727832,0.030915901],"genre_scores_gemma":[0.94188195,0.04186479,0.006806679,0.0013352878,0.00053704355,0.00011404011,0.00035197462,0.000017922994,0.007090237],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99997795,0.0000073924925,0.0000020695174,0.0000032466737,0.000004118511,0.0000052591477],"domain_scores_gemma":[0.9999825,0.0000052022046,0.000004739011,0.0000011489884,0.0000014421885,0.0000050162644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010223257,0.0001793502,0.00028540118,0.00017615999,0.0001474111,0.00022354869,0.00013694164,0.0002914045,0.002300859],"category_scores_gemma":[0.000080306876,0.00006679648,0.00021354154,0.0001207606,0.00013790952,0.00024301007,0.00014730517,0.0005180086,0.0005048138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009718358,0.0012579464,0.0023990097,0.0010735596,0.00013327722,0.004800315,0.0001761205,0.0011564754,0.14061366,0.0039112275,0.00741132,0.8273487],"study_design_scores_gemma":[0.024906754,0.051210165,0.056975197,0.0009005455,0.0008756592,0.085561894,0.00069664064,0.010018053,0.16871697,0.011488149,0.5884713,0.00017868006],"about_ca_topic_score_codex":0.000081566286,"about_ca_topic_score_gemma":0.0002683966,"teacher_disagreement_score":0.002300859,"about_ca_system_score_codex":0.00008158854,"about_ca_system_score_gemma":0.000095847616,"threshold_uncertainty_score":0.007697165},"labels":[],"label_agreement":null},{"id":"W2325941892","doi":"10.1358/dot.2000.36.2-3.568785","title":"Oral phentolamine (Vasomax(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Phentolamine; Medicine; Sympatholytic; Anesthesia; Internal medicine; Blood pressure; Propranolol","score_opus":0.011429716263223588,"score_gpt":0.26645212058433,"score_spread":0.2550224043211064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325941892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16095105,0.7759879,0.006060084,0.0015109967,0.0010528748,0.00019550702,0.0006659392,0.00047953957,0.05309612],"genre_scores_gemma":[0.42599002,0.50270975,0.008861817,0.002619957,0.0011875959,0.0001748127,0.0013538018,0.00006132442,0.057040986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999609,0.0000077818695,0.000003423838,0.000007845328,0.000013070827,0.000006884466],"domain_scores_gemma":[0.99996066,0.000013097738,0.000010917375,0.0000020229713,0.0000036556141,0.000009599131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010664648,0.00020479666,0.0002649202,0.0004110174,0.00012898436,0.00017630061,0.00016712699,0.00030027892,0.0053086793],"category_scores_gemma":[0.00014025725,0.000048905797,0.000113858354,0.0002193908,0.00010490248,0.00014651788,0.00016965422,0.00028081966,0.0019791063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064887916,0.00022986377,0.00086258573,0.0015530617,0.000026433185,0.0011211205,0.00005993999,0.000045508445,0.07428408,0.0008566276,0.006043036,0.9142688],"study_design_scores_gemma":[0.00063945254,0.011613255,0.024681145,0.0007274937,0.00021767216,0.024039876,0.00016942108,0.00024911243,0.07899443,0.000798277,0.85783887,0.000030993808],"about_ca_topic_score_codex":0.0002416566,"about_ca_topic_score_gemma":0.00044224336,"teacher_disagreement_score":0.0053086793,"about_ca_system_score_codex":0.000082927814,"about_ca_system_score_gemma":0.000106593514,"threshold_uncertainty_score":0.017759323},"labels":[],"label_agreement":null},{"id":"W2327987781","doi":"10.1358/dot.2014.50.1.2118308","title":"A report from the 16th IGPA conference (December 9-11, 2013 -Brussels, Belgium)","year":2014,"lang":"en","type":"article","venue":"Drugs of today","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alliance; Medicine; Negotiation; Member states; Economic growth; International trade; Political science; Business; Law","score_opus":0.042667258274655735,"score_gpt":0.26738202488049334,"score_spread":0.2247147666058376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327987781","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012471349,0.05798961,0.005672843,0.18375808,0.3257062,0.0017384668,0.036542904,0.0015708511,0.37454966],"genre_scores_gemma":[0.02618415,0.02039072,0.0045057205,0.018444337,0.027860904,0.001006993,0.020431021,0.0010188713,0.88015723],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970061,0.00041494003,0.00008555311,0.0002620818,0.0014545603,0.00077682047],"domain_scores_gemma":[0.99438757,0.00053191214,0.000247714,0.00016337364,0.0028304493,0.0018389178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004975792,0.0013831945,0.0007300896,0.0019804894,0.0021571089,0.008237376,0.0015228848,0.0042072153,0.12361184],"category_scores_gemma":[0.007170246,0.00045743646,0.0010805653,0.0020754691,0.00062179036,0.002464819,0.0025662577,0.0039679348,0.052068625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006188677,0.00003864754,0.00024413771,0.00011334979,0.000005325104,0.000065263426,0.00004374248,0.00007377493,0.00011260517,0.0003815558,0.9885566,0.010303023],"study_design_scores_gemma":[0.000013482052,0.000030930198,0.0025180704,0.00019077046,0.000007524609,0.000038111397,0.00025798322,0.00006810419,0.00018396691,0.000209489,0.99646735,0.000014171902],"about_ca_topic_score_codex":0.027056774,"about_ca_topic_score_gemma":0.036341798,"teacher_disagreement_score":0.12361184,"about_ca_system_score_codex":0.004101135,"about_ca_system_score_gemma":0.009297179,"threshold_uncertainty_score":0.41352278},"labels":[],"label_agreement":null},{"id":"W2334764107","doi":"10.1358/dot.2013.49.9.2056599","title":"A report from the European Society of Cardiology Congress 2013(August 31-September 4, 2013 - Amsterdam, The Netherlands)","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Attendance; Session (web analytics); Canadian Cardiovascular Society; Convention; Alternative medicine; Medical education; Preclinical research; Family medicine; Medical physics; Internal medicine; Myocardial infarction; Pathology; Law; Political science","score_opus":0.011105435313271867,"score_gpt":0.23600798532777226,"score_spread":0.22490255001450038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334764107","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0116850585,0.094486825,0.0037109053,0.1663896,0.3599197,0.0020125895,0.0881017,0.0013079033,0.27238575],"genre_scores_gemma":[0.040665783,0.09616295,0.004749637,0.03718906,0.07723625,0.0016837263,0.07665301,0.0010156425,0.6646439],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976041,0.00020724363,0.00020290191,0.0001633796,0.0014514144,0.000371029],"domain_scores_gemma":[0.99491054,0.0003607437,0.00037555365,0.00013198533,0.003063504,0.0011577745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004344232,0.0012159924,0.0007222043,0.0031887507,0.0010564392,0.0045620715,0.0009524122,0.0028873838,0.07487299],"category_scores_gemma":[0.005242772,0.00040059467,0.00092502654,0.0031519816,0.00033178306,0.0014858108,0.0018687967,0.0026484772,0.03884877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006481752,0.00004015035,0.00059587666,0.00024264917,0.000011992162,0.00010389924,0.000035444118,0.0000434531,0.00014136078,0.00021095583,0.9770621,0.02144736],"study_design_scores_gemma":[0.000019263724,0.00004975284,0.006288287,0.00034668288,0.000022070953,0.000104595456,0.00016148371,0.000043795862,0.0002857222,0.00013691188,0.99252135,0.000020084528],"about_ca_topic_score_codex":0.01244381,"about_ca_topic_score_gemma":0.016377218,"teacher_disagreement_score":0.07487299,"about_ca_system_score_codex":0.0021038353,"about_ca_system_score_gemma":0.0065977615,"threshold_uncertainty_score":0.25047517},"labels":[],"label_agreement":null},{"id":"W2339145532","doi":"10.1358/dot.2015.51.10.2401004","title":"Tavaborole topical solution, 5% for the treatment of toenailonychomycosis","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Trichophyton rubrum; Erythema; Nail (fastener); Clinical trial; Adverse effect; Antifungal; Dermatophyte; Internal medicine","score_opus":0.06903558764533257,"score_gpt":0.3846905140682847,"score_spread":0.3156549264229521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339145532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032176144,0.99868804,0.00006803481,0.00006759657,0.000049310085,0.000009779849,0.000025853335,0.000008310989,0.0007613301],"genre_scores_gemma":[0.0019455057,0.9971693,0.00018661721,0.000095148,0.000032785294,0.00001058767,0.000047275655,0.0000017789366,0.0005110087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998435,0.000027211507,0.000031336178,0.000024213798,0.00005926113,0.000014502897],"domain_scores_gemma":[0.99986017,0.0000594076,0.000033313172,0.0000038934695,0.000031660584,0.000011565613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034994667,0.0006757092,0.0011164784,0.003181682,0.00026588148,0.00061226013,0.0006307764,0.0006816721,0.004436098],"category_scores_gemma":[0.00040391315,0.00025672675,0.0008497422,0.001925873,0.0002476632,0.0007174511,0.0004545336,0.0009746575,0.0012927682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017308074,0.00014346339,0.0001997952,0.050327335,0.00026897385,0.0003346508,0.00008112224,0.00024626867,0.0034660054,0.0012226236,0.01727604,0.92626065],"study_design_scores_gemma":[0.00011008934,0.00033132598,0.0028434768,0.011880486,0.00085864746,0.0042965943,0.0001232874,0.00016042702,0.002139533,0.0010048717,0.9762162,0.000035135832],"about_ca_topic_score_codex":0.0013425996,"about_ca_topic_score_gemma":0.0031085592,"teacher_disagreement_score":0.004436098,"about_ca_system_score_codex":0.00033218597,"about_ca_system_score_gemma":0.0007334715,"threshold_uncertainty_score":0.014840245},"labels":[],"label_agreement":null},{"id":"W2376717750","doi":"10.1358/dot.2013.49.12.2067249","title":"Simeprevir for the treatment of genotype 1 chronic hepatitis Cvirus","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Simeprevir; Ribavirin; Medicine; Pegylated interferon; Virology; Hepatitis C virus; Genotype; Protease inhibitor (pharmacology); Interferon; Internal medicine; Pharmacology; Virus; Viral load; Biology","score_opus":0.027085152691921924,"score_gpt":0.3213115087311132,"score_spread":0.2942263560391913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2376717750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19626187,0.65919596,0.008873669,0.018850995,0.002905427,0.0006778206,0.0014490938,0.0012448853,0.11054028],"genre_scores_gemma":[0.7898209,0.14458081,0.009523297,0.009074242,0.002677024,0.00031356225,0.0023953703,0.000088799476,0.041526064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992216,0.00002493022,0.0000071365266,0.000009626931,0.000021898355,0.000014205827],"domain_scores_gemma":[0.9999323,0.000015990356,0.000013228786,0.0000044512826,0.000011863208,0.000022169352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028667256,0.000264412,0.00028523634,0.00032377525,0.0001956398,0.00013560842,0.00015950807,0.00031239804,0.0055176066],"category_scores_gemma":[0.0002844835,0.000041321524,0.00024905056,0.00022316856,0.00011359451,0.0001820709,0.00015289016,0.00069947145,0.0016332904],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002001249,0.00040768713,0.0028585517,0.0009081742,0.00008144878,0.0015970542,0.00009699652,0.00021244177,0.024215145,0.0027028203,0.041455083,0.9234632],"study_design_scores_gemma":[0.0034231425,0.0066529517,0.023056876,0.0005983144,0.0001494301,0.018582536,0.00008425781,0.0010816994,0.019952193,0.0035690444,0.9228099,0.00003952147],"about_ca_topic_score_codex":0.00020930776,"about_ca_topic_score_gemma":0.00052720646,"teacher_disagreement_score":0.0055176066,"about_ca_system_score_codex":0.00019047815,"about_ca_system_score_gemma":0.0002914645,"threshold_uncertainty_score":0.018458247},"labels":[],"label_agreement":null},{"id":"W2398096896","doi":"10.1358/dot.2015.51.12.2420391","title":"Patiromer: A significant advance in the management of hyperkalemia","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyperkalemia; Medicine; Spironolactone; Kidney disease; Heart failure; Aldosterone; Adverse effect; Internal medicine; Urology","score_opus":0.029521000107332867,"score_gpt":0.3355143980820784,"score_spread":0.3059933979747455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398096896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014481573,0.9982911,0.00010624481,0.00032960932,0.00014802828,0.000003869465,0.000012560367,0.000009818952,0.0009539663],"genre_scores_gemma":[0.0011693849,0.99757737,0.00020668663,0.0003130527,0.00020686173,0.000004093008,0.00003442396,0.0000021104854,0.0004860989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977964,0.00003341842,0.000043914406,0.00004214826,0.00008009273,0.000020887757],"domain_scores_gemma":[0.99967015,0.00014395893,0.000054343545,0.000009483129,0.000089460234,0.000032528093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050524366,0.00068623584,0.0010012429,0.0027439294,0.00024230928,0.00078554015,0.0006643688,0.0008616655,0.0033939423],"category_scores_gemma":[0.0006313421,0.00021555403,0.00066941493,0.0016163813,0.00045941057,0.0012910044,0.0007105451,0.002531983,0.0016534587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092782604,0.00010700284,0.0002507659,0.012724267,0.00009486999,0.00025792173,0.00005966212,0.0002035934,0.0011710569,0.002235553,0.020907007,0.9618954],"study_design_scores_gemma":[0.00004868602,0.00015686719,0.0015387757,0.003847987,0.000121718935,0.0036693614,0.00005836736,0.00009962769,0.00052862667,0.0014794403,0.988425,0.000025572725],"about_ca_topic_score_codex":0.0009179591,"about_ca_topic_score_gemma":0.0020657,"teacher_disagreement_score":0.0033939423,"about_ca_system_score_codex":0.00045899954,"about_ca_system_score_gemma":0.0008141435,"threshold_uncertainty_score":0.01135391},"labels":[],"label_agreement":null},{"id":"W2410968598","doi":"10.1358/dot.2004.40.7.850479","title":"Recent developments in lipid-lowering therapy - Highlights from theAtorvastatin Landmark Program: Global Investigators Meeting III","year":2004,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Landmark; Guideline; Clinical trial; Clinical Practice; Modalities; Medical physics; Family medicine; Pharmacology; Pathology; Artificial intelligence; Computer science","score_opus":0.015449924834143256,"score_gpt":0.27475283255909616,"score_spread":0.2593029077249529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410968598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007636043,0.5581957,0.0019221996,0.3677076,0.04903015,0.00018519015,0.0007983169,0.00012470674,0.0144001115],"genre_scores_gemma":[0.064604566,0.5839089,0.011569673,0.14576524,0.14959246,0.0004094522,0.0028289813,0.00015520537,0.041165605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874675,0.0004384208,0.00012801334,0.00009347123,0.00037400832,0.00021940943],"domain_scores_gemma":[0.99575543,0.00090518757,0.00040005666,0.00006491168,0.0016355276,0.0012390253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067002126,0.00061320764,0.0007075112,0.00095723826,0.00041181175,0.0023596932,0.0010251953,0.0032016446,0.0032317517],"category_scores_gemma":[0.0039465353,0.00026212458,0.00065428024,0.001544852,0.00052109855,0.0010439566,0.00096235785,0.0032295866,0.0010367236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015604533,0.00016723946,0.003072161,0.0029265855,0.00011298636,0.00051383825,0.00017025828,0.00039068967,0.0021920293,0.0034327568,0.69528353,0.29017752],"study_design_scores_gemma":[0.00030137104,0.0005296038,0.010385701,0.0013826746,0.00025385563,0.0006257705,0.0001896964,0.00021978824,0.00097873,0.0012835433,0.98381215,0.000037235885],"about_ca_topic_score_codex":0.0029806048,"about_ca_topic_score_gemma":0.014748022,"teacher_disagreement_score":0.0067002126,"about_ca_system_score_codex":0.0020704109,"about_ca_system_score_gemma":0.005013264,"threshold_uncertainty_score":0.035434544},"labels":[],"label_agreement":null},{"id":"W2412549228","doi":"10.1358/dot.2015.51.6.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20,2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychiatry; Association (psychology); Addiction; Theme (computing); Gerontology; Psychotherapist; Psychology","score_opus":0.01329601164486981,"score_gpt":0.2968485207447442,"score_spread":0.2835525090998744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412549228","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058243414,0.036892187,0.0013910211,0.12591499,0.1191194,0.0011665513,0.024146974,0.0013442567,0.68420035],"genre_scores_gemma":[0.006576013,0.015284738,0.0007021099,0.007059662,0.0052985405,0.00019027307,0.006907506,0.0001688693,0.95781225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914646,0.000058067923,0.000038641276,0.000066735076,0.0003418956,0.0003482509],"domain_scores_gemma":[0.99639195,0.00005063906,0.000075383505,0.000042282285,0.0017152503,0.0017243949],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001280393,0.0010724135,0.00074663316,0.0013202243,0.0030154209,0.00270669,0.0011918071,0.0026144711,0.30085537],"category_scores_gemma":[0.001642761,0.00046875371,0.00058857625,0.0011170582,0.00051726925,0.0010067511,0.0021244364,0.0028217537,0.14832339],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019131272,0.000015484999,0.00037045457,0.00003930434,0.000002976893,0.000024009723,0.000012025527,0.00001334604,0.00005239377,0.000080072496,0.98511165,0.014259215],"study_design_scores_gemma":[0.000016298984,0.000021077773,0.007805169,0.00023978858,0.000005040174,0.000058237016,0.00014748944,0.00004531591,0.00003560358,0.00008535709,0.99152994,0.000010628065],"about_ca_topic_score_codex":0.33488777,"about_ca_topic_score_gemma":0.7901212,"teacher_disagreement_score":0.33488777,"about_ca_system_score_codex":0.0079821935,"about_ca_system_score_gemma":0.019560764,"threshold_uncertainty_score":0.99724495},"labels":[],"label_agreement":null},{"id":"W2442538157","doi":"10.1358/dot.2015.51.5.2336329","title":"A report from the American Association of Urology Annual Meeting2015 (May 15-19 - New Orleans, Louisiana, USA)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Convention; Quarter (Canadian coin); Gerontology; Family medicine; Library science; Archaeology","score_opus":0.019357152547271227,"score_gpt":0.3010949530022958,"score_spread":0.28173780045502456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442538157","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0081326915,0.059067253,0.0033045996,0.2023597,0.46439466,0.0020413438,0.038103614,0.001070556,0.22152549],"genre_scores_gemma":[0.021644665,0.040273365,0.003189344,0.038113106,0.05271769,0.0010547484,0.035879184,0.00047568494,0.80665225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744594,0.000270243,0.00015858051,0.00017016531,0.0014936546,0.00046133166],"domain_scores_gemma":[0.9907279,0.000333765,0.00036375877,0.00015893337,0.0064322,0.001983418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00514728,0.0011698456,0.00062763895,0.0028559882,0.0017697142,0.0042376034,0.0011299207,0.0027136495,0.10912659],"category_scores_gemma":[0.0054130373,0.00037250682,0.00090500625,0.0018368108,0.00034627985,0.0015958657,0.0023152218,0.002525314,0.042498805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000342598,0.000044711844,0.000607756,0.00014471421,0.000008314769,0.0000360093,0.000018986084,0.000022862376,0.00013288273,0.000113174654,0.97693014,0.021906096],"study_design_scores_gemma":[0.000009696699,0.000043318145,0.0040395153,0.0002619991,0.000011870032,0.000045020857,0.00011638798,0.000038927614,0.0001893568,0.00008169439,0.99515,0.000012261178],"about_ca_topic_score_codex":0.016223596,"about_ca_topic_score_gemma":0.032417793,"teacher_disagreement_score":0.10912659,"about_ca_system_score_codex":0.0028418368,"about_ca_system_score_gemma":0.010006544,"threshold_uncertainty_score":0.36506486},"labels":[],"label_agreement":null},{"id":"W2526768593","doi":"10.1358/dot.2017.53.6.2662982","title":"Notable deals in the pharmaceutical industry in the first quarterof 2017","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry","score_opus":0.171942251902463,"score_gpt":0.40503993652769343,"score_spread":0.23309768462523042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526768593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012323717,0.98969203,0.00008224654,0.00087009615,0.00028312896,0.000013691803,0.0001470505,0.00001188994,0.007667493],"genre_scores_gemma":[0.0062648207,0.9901272,0.000143211,0.0004364641,0.00022009872,0.000007817591,0.00019359437,0.0000031662403,0.002603618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993162,0.00008665672,0.000074354415,0.00007152941,0.00037722063,0.00007402937],"domain_scores_gemma":[0.9992482,0.00021181132,0.00025069778,0.000013518142,0.00021246923,0.00006323369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008925055,0.00057411904,0.00050563004,0.0037096946,0.00045954526,0.0029642393,0.00048642902,0.00093689584,0.0059243087],"category_scores_gemma":[0.0016473258,0.00024333375,0.0004562739,0.006515613,0.00043402868,0.0019316614,0.0010998218,0.0011155045,0.0019444182],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082180835,0.00004909357,0.0013310165,0.01351194,0.00008102225,0.0002923093,0.00024118679,0.00018714895,0.0008026529,0.0061000655,0.036987588,0.9403337],"study_design_scores_gemma":[0.00000705942,0.000056997636,0.0042931666,0.0050595207,0.000097203905,0.00089596654,0.0002620951,0.000051775227,0.0005089984,0.00074107543,0.98800975,0.000016381337],"about_ca_topic_score_codex":0.0033039688,"about_ca_topic_score_gemma":0.009615022,"teacher_disagreement_score":0.0059243087,"about_ca_system_score_codex":0.0014746808,"about_ca_system_score_gemma":0.002456496,"threshold_uncertainty_score":0.019818783},"labels":[],"label_agreement":null},{"id":"W2527154090","doi":"10.1358/dot.2016.52.8.2545018","title":"Notable deals in the pharmaceutical industry in the second quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.028387175496601576,"score_gpt":0.28666359607740216,"score_spread":0.2582764205808006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527154090","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37401304,0.07046196,0.0015894076,0.033903547,0.006996502,0.00018983943,0.0035797774,0.0004342361,0.50883174],"genre_scores_gemma":[0.6518035,0.03178024,0.0016722104,0.003895672,0.0038595283,0.00006187969,0.0042437143,0.00012098922,0.30256227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747616,0.0001865417,0.00010142938,0.00014706998,0.0016418699,0.00044689406],"domain_scores_gemma":[0.9972162,0.00032783506,0.0008598196,0.00012587754,0.0007336623,0.00073654565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020767525,0.00040803925,0.00030458512,0.002547279,0.0021272586,0.00909939,0.00043736483,0.0013880195,0.009210893],"category_scores_gemma":[0.003887129,0.00027624427,0.00030921414,0.0049316445,0.0010264458,0.0026070892,0.002609445,0.0015526445,0.0026627355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000626819,0.00024521467,0.059970975,0.000874219,0.000059992235,0.0030316482,0.007749144,0.00055533164,0.0075807464,0.088315375,0.30425417,0.5267364],"study_design_scores_gemma":[0.000010989821,0.00009387635,0.0740766,0.00018764916,0.000011241803,0.00086926034,0.0021292027,0.000239836,0.0019215876,0.0015971647,0.9188355,0.00002711429],"about_ca_topic_score_codex":0.005077425,"about_ca_topic_score_gemma":0.012662213,"teacher_disagreement_score":0.009210893,"about_ca_system_score_codex":0.0044450825,"about_ca_system_score_gemma":0.0024176615,"threshold_uncertainty_score":0.032251418},"labels":[],"label_agreement":null},{"id":"W2701201582","doi":"10.1358/dot.2017.53.5.2613690","title":"Brodalumab: The first anti-IL-17 receptor agent for psoriasis","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Psoriasis Area and Severity Index; Psoriasis; Ustekinumab; Psoriatic arthritis; Dermatology; Interleukin 17; Clinical trial; Erythroderma; Immunology; Internal medicine; Adalimumab; Immune system; Disease","score_opus":0.06135471088143997,"score_gpt":0.31812742397030314,"score_spread":0.2567727130888632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2701201582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093549155,0.7029866,0.011133464,0.016856521,0.016961804,0.0020227837,0.0063195433,0.004006501,0.14616355],"genre_scores_gemma":[0.41211858,0.3253724,0.021392584,0.038331624,0.005531207,0.0015763834,0.011640873,0.00054603134,0.18349025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975735,0.000034109813,0.0000145939775,0.000037993283,0.00008807617,0.00006798818],"domain_scores_gemma":[0.99980956,0.000019402958,0.000024190866,0.00000946201,0.00005497455,0.000082484476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040901013,0.0007321572,0.00060687255,0.00052160694,0.0003478382,0.0009108399,0.00058080535,0.0010429248,0.007306969],"category_scores_gemma":[0.00046452112,0.00020695318,0.00058922113,0.00021527041,0.0002144434,0.00044299944,0.00045338468,0.002635266,0.006258456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002542682,0.00083237415,0.0009901704,0.0015885475,0.00018651046,0.0012557938,0.00008180101,0.0002893801,0.034868024,0.0016641039,0.14740555,0.80829513],"study_design_scores_gemma":[0.0027367154,0.0032319187,0.0037432767,0.0004611696,0.00014753465,0.0036412645,0.00001551073,0.00037247717,0.014933527,0.0003226872,0.97035325,0.00004068579],"about_ca_topic_score_codex":0.0008537576,"about_ca_topic_score_gemma":0.0020404973,"teacher_disagreement_score":0.007306969,"about_ca_system_score_codex":0.000566823,"about_ca_system_score_gemma":0.0006205406,"threshold_uncertainty_score":0.024444222},"labels":[],"label_agreement":null},{"id":"W2766470987","doi":"10.1358/dot.2017.53.8.2701432","title":"Notable licensing deals in the biopharma industry in the secondquarter of 2017","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine","score_opus":0.024488112195380034,"score_gpt":0.31985902365674423,"score_spread":0.2953709114613642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766470987","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25189614,0.024765635,0.0026083635,0.027426034,0.007828596,0.00035510722,0.0050427155,0.0009969054,0.6790805],"genre_scores_gemma":[0.377592,0.016193435,0.0015713291,0.0061521255,0.0038110176,0.00013616681,0.0064140097,0.00035459263,0.5877753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974076,0.00012359791,0.00007537706,0.00017824343,0.0017477097,0.0004674253],"domain_scores_gemma":[0.9968154,0.0005391351,0.00062056707,0.0001329606,0.0009083947,0.0009836036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017023026,0.00048473722,0.00025728715,0.002237476,0.0019733065,0.00821282,0.000488361,0.001364078,0.024866713],"category_scores_gemma":[0.0043167677,0.0002542662,0.00046854466,0.0027630527,0.001033244,0.0028751637,0.0024976018,0.0022133747,0.00800538],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000575718,0.00024367849,0.031336192,0.00079031155,0.00005106278,0.0029953062,0.0045967926,0.00045216279,0.010797913,0.08405472,0.4919445,0.37216166],"study_design_scores_gemma":[0.000015234026,0.00009320793,0.028683735,0.00012208702,0.000010943073,0.00068971433,0.0012680261,0.00022542244,0.0032426782,0.0012218824,0.9644028,0.00002424012],"about_ca_topic_score_codex":0.004938409,"about_ca_topic_score_gemma":0.008608371,"teacher_disagreement_score":0.024866713,"about_ca_system_score_codex":0.0045011737,"about_ca_system_score_gemma":0.0042105527,"threshold_uncertainty_score":0.0831874},"labels":[],"label_agreement":null},{"id":"W2793596767","doi":"10.1358/dot.2017.53.12.2717629","title":"European Society of Cardiology Congress 2017 (August 26-30, 2017 -Barcelona, Spain)","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Coronary artery disease; Canadian Cardiovascular Society; Coronary heart disease; Cardiology; Interventional cardiology; Internal medicine; Myocardial infarction; Angina","score_opus":0.03421157514825694,"score_gpt":0.31302736387924857,"score_spread":0.2788157887309916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793596767","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003714476,0.15976283,0.0024083315,0.047452632,0.31953293,0.00047459194,0.009324349,0.0015392699,0.45579064],"genre_scores_gemma":[0.021154705,0.07879031,0.002706239,0.014011782,0.068419956,0.0005125631,0.015598625,0.00087507383,0.7979308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987437,0.00016682221,0.00011602832,0.00019535622,0.00047204082,0.00030595146],"domain_scores_gemma":[0.99733317,0.00012102051,0.00018596313,0.00008287237,0.0012317174,0.0010452981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025406096,0.0012306225,0.0009079891,0.0021420491,0.00070993626,0.0052872463,0.001104242,0.0027270878,0.1994741],"category_scores_gemma":[0.0028044987,0.00026687936,0.0007785989,0.0009717154,0.00047308143,0.0013436774,0.0025256637,0.0022968997,0.16476052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009315369,0.000033952805,0.00032933132,0.00021038344,0.000011254588,0.000090984686,0.000019988263,0.000049566115,0.00019323037,0.00088890124,0.9285029,0.06957629],"study_design_scores_gemma":[0.000022684488,0.000022897646,0.001421762,0.00032431106,0.0000053316935,0.0001636662,0.000042052965,0.000029269697,0.000106867934,0.0002854049,0.99756867,0.0000070576302],"about_ca_topic_score_codex":0.0019041202,"about_ca_topic_score_gemma":0.0025865948,"teacher_disagreement_score":0.1994741,"about_ca_system_score_codex":0.0018719452,"about_ca_system_score_gemma":0.0031882431,"threshold_uncertainty_score":0.6673073},"labels":[],"label_agreement":null},{"id":"W2796263169","doi":"10.1358/dot.2018.54.10.2909247","title":"Life sciences licensing deals in the second quarter of 2018:updates and trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; License; Portfolio; Value (mathematics); Finance; Business; Law","score_opus":0.009292596359820824,"score_gpt":0.23276833504700076,"score_spread":0.22347573868717993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796263169","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22181217,0.16006601,0.0028476592,0.08795431,0.009366747,0.00018371812,0.05455867,0.0016621626,0.4615486],"genre_scores_gemma":[0.4980786,0.14193839,0.0025761423,0.021291902,0.014594846,0.0002495013,0.07271726,0.0010024933,0.24755095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997177,0.00012994949,0.00024842832,0.00032573388,0.0017782397,0.0003406481],"domain_scores_gemma":[0.98172414,0.0024146552,0.0070681022,0.00025165806,0.006716003,0.0018254719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019426959,0.00050907134,0.00038048782,0.007092012,0.00072524656,0.008617051,0.00087949727,0.0018002532,0.022153137],"category_scores_gemma":[0.01273362,0.00032198895,0.00039468304,0.012708646,0.00066857773,0.008037973,0.0015495465,0.0022609625,0.010381234],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032297513,0.00026246312,0.07769366,0.000802858,0.0000362834,0.00052766444,0.0010761018,0.00032354714,0.000791796,0.016418118,0.5841736,0.3175709],"study_design_scores_gemma":[0.000015387343,0.000059545087,0.06726169,0.00039162472,0.0000152401035,0.00062840653,0.0010243907,0.00030571126,0.0006186866,0.00058837736,0.9290649,0.000026030471],"about_ca_topic_score_codex":0.013672279,"about_ca_topic_score_gemma":0.013231418,"teacher_disagreement_score":0.022153137,"about_ca_system_score_codex":0.0040190048,"about_ca_system_score_gemma":0.0026538253,"threshold_uncertainty_score":0.074109614},"labels":[],"label_agreement":null},{"id":"W2804667058","doi":"10.1358/dot.2018.54.4.2795154","title":"Daclatasvir, asunaprevir and beclabuvir fixed-dose combination forpatients with genotype 1 chronic hepatitis C","year":2018,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Infectious Diseases Centre","funders":"","keywords":"Daclatasvir; Medicine; Internal medicine; Hepatitis C; Regimen; Hepatitis C virus; Virology; Adverse effect; Gastroenterology; Virus; Ribavirin","score_opus":0.03751225994869992,"score_gpt":0.34831314644824135,"score_spread":0.3108008864995414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804667058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010437802,0.9990559,0.000036419817,0.00011184903,0.00007025522,0.000005862963,0.000016009315,0.0000053435297,0.0005939844],"genre_scores_gemma":[0.0007858667,0.9984951,0.00010755413,0.00010459308,0.00006113662,0.000006770857,0.000029060075,0.0000010561415,0.0004087764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980384,0.000045663946,0.0000325474,0.000028187045,0.000074367155,0.000015371033],"domain_scores_gemma":[0.99973315,0.00013212996,0.00005372149,0.000008466683,0.000052480285,0.00002007368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045698474,0.00060073816,0.0013144829,0.0023070122,0.0002567253,0.00058272976,0.0006802286,0.00069548294,0.005012533],"category_scores_gemma":[0.000689465,0.00017210997,0.0006756239,0.0019561313,0.00029700212,0.0007208119,0.00048775805,0.0012157243,0.0019882862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009627588,0.000053090305,0.0001233551,0.026511924,0.0001472686,0.00011574842,0.00004018485,0.00010689513,0.00067314546,0.0008804253,0.021544948,0.9497067],"study_design_scores_gemma":[0.00008835477,0.00016343857,0.0014880967,0.010195034,0.00047992484,0.0022951441,0.0000742313,0.00009050743,0.0004517306,0.00093356887,0.9837203,0.000019640993],"about_ca_topic_score_codex":0.0009472214,"about_ca_topic_score_gemma":0.0020983596,"teacher_disagreement_score":0.005012533,"about_ca_system_score_codex":0.0003388956,"about_ca_system_score_gemma":0.0007683244,"threshold_uncertainty_score":0.016768634},"labels":[],"label_agreement":null},{"id":"W2852054128","doi":"10.1358/dot.2018.54.6.2856494","title":"Life sciences licensing deals in the first quarter of 2018: updatesand trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Value (mathematics); Medicine; Statistics; Mathematics","score_opus":0.06580677129434757,"score_gpt":0.3849955914596011,"score_spread":0.3191888201652535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2852054128","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48571128,0.14238483,0.0029177407,0.04243981,0.0045981584,0.00017676968,0.06291111,0.0012827454,0.25757748],"genre_scores_gemma":[0.6845044,0.12349322,0.0031531202,0.0067582056,0.008378687,0.00024461732,0.06465667,0.0005727014,0.10823834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716896,0.00016747614,0.00033435755,0.00036538873,0.0015977471,0.0003660605],"domain_scores_gemma":[0.9796768,0.0029368752,0.009493961,0.0003932785,0.00599673,0.0015023169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021078235,0.00042817398,0.0003708148,0.007350842,0.00058078323,0.0062547657,0.00081653846,0.001234211,0.014527617],"category_scores_gemma":[0.013603767,0.0003142854,0.0004312486,0.012213453,0.0005092378,0.0069057285,0.0015332308,0.001795756,0.005932317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000514436,0.0004070515,0.17713112,0.0013700322,0.00006369203,0.00050907454,0.0021906858,0.00047729636,0.0013096117,0.010740301,0.25916922,0.54611754],"study_design_scores_gemma":[0.000020784726,0.00011553189,0.20408593,0.0005872495,0.00002946708,0.0010286773,0.0016598487,0.0004561027,0.0013869151,0.0006043174,0.78999376,0.000031425243],"about_ca_topic_score_codex":0.01005757,"about_ca_topic_score_gemma":0.008811505,"teacher_disagreement_score":0.014527617,"about_ca_system_score_codex":0.0027903535,"about_ca_system_score_gemma":0.0019143124,"threshold_uncertainty_score":0.04859972},"labels":[],"label_agreement":null},{"id":"W2942062551","doi":"10.1358/dot.2019.55.4.2958476","title":"Encorafenib and binimetinib for the treatment of BRAFV600E/K-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Melanoma; MAPK/ERK pathway; Metastatic melanoma; V600E; Cancer research; Oncology; Kinase; Pharmacology; Mutation; Internal medicine; Biology; Genetics","score_opus":0.04074034639323368,"score_gpt":0.3182639523817377,"score_spread":0.277523605988504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942062551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028495432,0.99660563,0.00014299805,0.00025735254,0.0002481832,0.000009359041,0.000044831504,0.00001316623,0.0023935202],"genre_scores_gemma":[0.001192986,0.996086,0.00020015152,0.00029960292,0.00013199037,0.000011061605,0.00008576901,0.0000022477345,0.0019902224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999064,0.000012302604,0.0000122422125,0.000016744278,0.000041262894,0.000010979427],"domain_scores_gemma":[0.99991775,0.0000286588,0.000015141136,0.000002434205,0.000024132647,0.000011991934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024816385,0.000605996,0.0007171097,0.0018839237,0.0001956706,0.00052213523,0.0005480084,0.000652875,0.0047165737],"category_scores_gemma":[0.000325389,0.00016606,0.0004178761,0.0012070179,0.00019475685,0.00071888283,0.00039551427,0.0014560325,0.0023411436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008522425,0.00007563192,0.00011568633,0.0081812795,0.00007345725,0.00019151463,0.000035497156,0.00027732208,0.002285357,0.0019600121,0.033762332,0.9529568],"study_design_scores_gemma":[0.000024894809,0.00009980304,0.00052995066,0.0012788826,0.00006886985,0.0013289445,0.000018119375,0.00006627305,0.0005066556,0.0006992474,0.99536824,0.000010163671],"about_ca_topic_score_codex":0.0007050188,"about_ca_topic_score_gemma":0.0023236023,"teacher_disagreement_score":0.0047165737,"about_ca_system_score_codex":0.0003901703,"about_ca_system_score_gemma":0.0005359141,"threshold_uncertainty_score":0.015778542},"labels":[],"label_agreement":null},{"id":"W2985958489","doi":"10.1358/dot.2019.55.10.3045038","title":"Viltolarsen for the treatment of Duchenne muscular dystrophy","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Dystrophin; Exon skipping; Exon; Medicine; Morpholino; RNA splicing; Muscular dystrophy; Alternative splicing; Bioinformatics; Genetics; Internal medicine; Gene; Gene knockdown; RNA; Biology","score_opus":0.030203488749806395,"score_gpt":0.32160060725396694,"score_spread":0.29139711850416056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985958489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051255786,0.9970067,0.00017295603,0.00018381984,0.00015954819,0.000008088312,0.00003878837,0.000018499468,0.0018990277],"genre_scores_gemma":[0.0031924073,0.99435246,0.00029684487,0.00028243754,0.00012378833,0.000012337117,0.00010152675,0.000003982548,0.0016343028],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9999181,0.000012705742,0.000013324802,0.000017167113,0.000029174851,0.000009457696],"domain_scores_gemma":[0.9999335,0.000030095911,0.000012428495,0.0000018870297,0.000012524528,0.000009616278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019078242,0.00051621546,0.0008082153,0.0014782076,0.00017549824,0.0004379663,0.0005319123,0.0005862472,0.0042904094],"category_scores_gemma":[0.0002131579,0.0001366819,0.00035949153,0.0008533392,0.00018449126,0.00049779133,0.00032457412,0.0013325562,0.0018933881],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015610007,0.00009947773,0.000119221964,0.011160172,0.00010080424,0.0002889163,0.000041698102,0.0002043903,0.0038718313,0.0013921907,0.017183026,0.9653823],"study_design_scores_gemma":[0.00006974518,0.0002752652,0.0010793674,0.001979032,0.00015942709,0.0030211662,0.00003585534,0.00008614228,0.0016409707,0.0007483301,0.99088776,0.000016837657],"about_ca_topic_score_codex":0.00042589818,"about_ca_topic_score_gemma":0.0011322654,"teacher_disagreement_score":0.0042904094,"about_ca_system_score_codex":0.00027716046,"about_ca_system_score_gemma":0.0003464942,"threshold_uncertainty_score":0.014352798},"labels":[],"label_agreement":null},{"id":"W3006524053","doi":"10.1358/dot.2020.56.1.3069863","title":"Galcanezumab: a humanized monoclonal antibody for the prevention ofmigraine and cluster headache","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Migraine; Medicine; Triptans; Calcitonin gene-related peptide; Cluster headache; Chronic Migraine; Headaches; Clinical trial; Rizatriptan; Pharmacology; Bioinformatics; Internal medicine; Sumatriptan; Receptor; Psychiatry; Neuropeptide","score_opus":0.03827635726970599,"score_gpt":0.3370591633159204,"score_spread":0.29878280604621443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006524053","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82728386,0.11973744,0.0028777611,0.0052731135,0.001970323,0.0012066175,0.0012613588,0.0012238027,0.03916575],"genre_scores_gemma":[0.952611,0.0246092,0.002847568,0.0027369207,0.00045376818,0.00029302016,0.001375644,0.000031976826,0.015040909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992096,0.0000143123,0.0000035087048,0.000011191027,0.000022337306,0.000027806229],"domain_scores_gemma":[0.9999578,0.000004588094,0.0000066537727,0.0000026257107,0.000008214354,0.000020077061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020837504,0.0003288892,0.00030180812,0.00037440762,0.00025263772,0.00029541756,0.0003358211,0.0006210876,0.0033593758],"category_scores_gemma":[0.00017165107,0.00008418368,0.0002724355,0.00022353484,0.00020714113,0.00024974538,0.00018249184,0.0007895413,0.00076492806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012152837,0.0049255798,0.0032248828,0.0012407517,0.0002859979,0.0013085668,0.00013507807,0.00037761914,0.16065578,0.0015794613,0.03091464,0.78319883],"study_design_scores_gemma":[0.043199316,0.07151654,0.09070293,0.00047717607,0.0010047351,0.018686993,0.00015810356,0.0027893116,0.16621996,0.0013400575,0.60375136,0.00015344353],"about_ca_topic_score_codex":0.0012216398,"about_ca_topic_score_gemma":0.0027269167,"teacher_disagreement_score":0.0033593758,"about_ca_system_score_codex":0.0004994884,"about_ca_system_score_gemma":0.0004870781,"threshold_uncertainty_score":0.011238217},"labels":[],"label_agreement":null},{"id":"W3047556542","doi":"10.1358/dot.2020.56.8.3159186","title":"Golodirsen for Duchenne muscular dystrophy","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Exon skipping; Duchenne muscular dystrophy; Exon; Medicine; Dystrophin; Morpholino; Muscular dystrophy; Gene; Bioinformatics; Genetics; Antisense therapy; Internal medicine; Gene knockdown; Biology; Oligonucleotide; Alternative splicing","score_opus":0.0094307765891266,"score_gpt":0.23215111052016882,"score_spread":0.2227203339310422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047556542","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09712142,0.6938637,0.005530341,0.056215856,0.009959509,0.00058503245,0.0019249126,0.001572117,0.13322707],"genre_scores_gemma":[0.413173,0.29452544,0.011650189,0.047777455,0.0054458915,0.00054324826,0.0029702582,0.0002248252,0.22368975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999858,0.00003652279,0.000011226013,0.000024170222,0.000042117008,0.000028004972],"domain_scores_gemma":[0.9998919,0.000024695746,0.000023739047,0.000005750759,0.00001872498,0.000035233716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036012058,0.0004207593,0.00042557574,0.00044974333,0.00027304425,0.0003886579,0.00023442552,0.00083079835,0.010694797],"category_scores_gemma":[0.00040393588,0.000057442187,0.00036411817,0.00025336258,0.00023246242,0.0003558146,0.0003645105,0.001442214,0.004190814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035167607,0.00045882846,0.00094330177,0.0017416991,0.00010689101,0.00288773,0.00013608467,0.00023689058,0.029020926,0.014359862,0.115953214,0.8306379],"study_design_scores_gemma":[0.0012464104,0.0027069598,0.004028795,0.0004363744,0.00007560791,0.004920297,0.000044658085,0.000119161276,0.0058937157,0.0018246425,0.9786744,0.000028969807],"about_ca_topic_score_codex":0.0002534201,"about_ca_topic_score_gemma":0.00082887453,"teacher_disagreement_score":0.010694797,"about_ca_system_score_codex":0.0003979275,"about_ca_system_score_gemma":0.0003805268,"threshold_uncertainty_score":0.035777688},"labels":[],"label_agreement":null},{"id":"W3119281289","doi":"10.1358/dot.2021.57.1.3211618","title":"Apomorphine hydrochloride: A sublingual tablet for the OFF episodesin Parkinson's disease","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Apomorphine; Levodopa; Parkinson's disease; Disease; Pediatrics; Anesthesia; Dopamine; Internal medicine; Dopaminergic","score_opus":0.018341829861007318,"score_gpt":0.2748438631171107,"score_spread":0.2565020332561034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119281289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9081858,0.048705284,0.0041795727,0.003410848,0.0006175288,0.0005694196,0.00081334927,0.000894221,0.03262405],"genre_scores_gemma":[0.95905286,0.015219273,0.0031660995,0.0013844862,0.00023026166,0.00012643026,0.00037260097,0.000029998477,0.020418057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99997556,0.0000039728484,0.000001698399,0.0000044074336,0.000010014121,0.0000044313138],"domain_scores_gemma":[0.9999769,0.0000030653257,0.0000040777627,0.0000012080382,0.0000025962538,0.000012203942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057977875,0.00019548541,0.0002360586,0.00023795404,0.0001697644,0.00010392624,0.00016072304,0.00032812223,0.0021856793],"category_scores_gemma":[0.00009100846,0.00006083288,0.00012755237,0.00008397658,0.00009217012,0.00014142525,0.00011114193,0.00057586207,0.0006009718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005374602,0.0028662367,0.002025592,0.0009751787,0.00009946974,0.0045558354,0.00027018017,0.00020860104,0.21045424,0.0012379852,0.022103943,0.74982816],"study_design_scores_gemma":[0.019013636,0.07347718,0.21260177,0.00070209365,0.0004056652,0.05643915,0.00053931336,0.005329209,0.14002587,0.0015988091,0.48969007,0.00017739633],"about_ca_topic_score_codex":0.0005528324,"about_ca_topic_score_gemma":0.0026488197,"teacher_disagreement_score":0.0021856793,"about_ca_system_score_codex":0.00008517576,"about_ca_system_score_gemma":0.00012651196,"threshold_uncertainty_score":0.007311821},"labels":[],"label_agreement":null},{"id":"W3120200411","doi":"10.1358/dot.2021.57.1.3233361","title":"Recombinant vesicular stomatitis virus expressing Ebola virusglycoprotein (rVSV-EBOV), a new Ebola vaccine","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Ebola vaccine; Ebola virus; Virology; Vesicular stomatitis virus; Ebolavirus; Sierra leone; Outbreak; Medicine; Vaccination; Virus","score_opus":0.01607867106629849,"score_gpt":0.2971816121544201,"score_spread":0.2811029410881216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120200411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9215739,0.04830281,0.008035836,0.0028567952,0.0011883198,0.0006546875,0.0018117242,0.0004164556,0.015159474],"genre_scores_gemma":[0.9678269,0.012096508,0.0072939033,0.0007799214,0.00018781108,0.00022282176,0.0018067396,0.000016650498,0.009768567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999076,0.000027646809,0.000006838961,0.000013343533,0.00002891732,0.000015671865],"domain_scores_gemma":[0.99996376,0.0000049026353,0.000010406264,0.00000346428,0.0000064311616,0.00001112119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034491977,0.00017390707,0.0002548895,0.00019826734,0.00009053687,0.00023573339,0.00015388765,0.00028610977,0.0014126323],"category_scores_gemma":[0.00016823596,0.000073983756,0.0001588619,0.000088719455,0.00016902834,0.00020645143,0.00016371881,0.00043702647,0.00039423705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053022318,0.002225595,0.0074806227,0.0009896638,0.00015532275,0.0005756509,0.00014176313,0.0011911616,0.6851591,0.004952568,0.015537309,0.27628905],"study_design_scores_gemma":[0.0059228595,0.040463503,0.045214567,0.00057499117,0.00048435543,0.006525829,0.0002457667,0.0037311746,0.43326023,0.0018589211,0.46164075,0.00007705182],"about_ca_topic_score_codex":0.0005353767,"about_ca_topic_score_gemma":0.0007989789,"teacher_disagreement_score":0.0014126323,"about_ca_system_score_codex":0.00025369448,"about_ca_system_score_gemma":0.00033180584,"threshold_uncertainty_score":0.0047256947},"labels":[],"label_agreement":null},{"id":"W3161179238","doi":"10.1358/dot.2021.57.5.3264119","title":"Remimazolam: a short-acting benzodiazepine for procedural sedation","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Benzodiazepine; Sedation; Anesthesia; Internal medicine","score_opus":0.0334317832994494,"score_gpt":0.31676419088883834,"score_spread":0.28333240758938893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161179238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18070002,0.6399166,0.08161872,0.009139273,0.0034414292,0.0007123462,0.0014170574,0.002902648,0.080151945],"genre_scores_gemma":[0.63505673,0.2399148,0.05461748,0.005074836,0.0018307107,0.00039097958,0.0017125161,0.0002193271,0.061182544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998222,0.000036901485,0.00002334768,0.000023548533,0.00006264918,0.0000313003],"domain_scores_gemma":[0.9998971,0.0000091763,0.000031609317,0.0000050934937,0.000029467928,0.000027531041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021876395,0.0004388357,0.00029750174,0.0005818254,0.0002202411,0.00030727722,0.0004426938,0.0004482968,0.0028726263],"category_scores_gemma":[0.00025208143,0.000099913545,0.00028611362,0.0002625946,0.00025900683,0.00039449777,0.0003837713,0.0008801545,0.0021042868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008327344,0.00032126598,0.00088355603,0.0023374246,0.000059049435,0.001975002,0.00012256313,0.0003010454,0.29930887,0.00530747,0.0151798865,0.673371],"study_design_scores_gemma":[0.00045396914,0.0048904894,0.009181411,0.0006033482,0.00009411694,0.03722073,0.00009085637,0.0010127021,0.20233676,0.0017570312,0.7422543,0.000104221595],"about_ca_topic_score_codex":0.00040616808,"about_ca_topic_score_gemma":0.00073224027,"teacher_disagreement_score":0.0028726263,"about_ca_system_score_codex":0.00032384778,"about_ca_system_score_gemma":0.00040878597,"threshold_uncertainty_score":0.009609878},"labels":[],"label_agreement":null},{"id":"W3189922281","doi":"10.1358/dot.2021.57.8.3293588","title":"Vibegron: a beta3-adrenergic agonist for the treatment ofoveractive bladder","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nocturia; Medicine; Overactive bladder; Anticholinergic; Agonist; Oxybutynin; Urology; Urinary urgency; Urinary incontinence; Anticholinergic agents; Urinary bladder; Adrenergic; Urinary system; Mirabegron; Internal medicine; Receptor; Pathology","score_opus":0.02997721073690499,"score_gpt":0.33147762763836036,"score_spread":0.30150041690145535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189922281","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21991873,0.59395283,0.008232647,0.016055968,0.0047492227,0.0010326677,0.008004622,0.0021633583,0.14588997],"genre_scores_gemma":[0.6289076,0.23361029,0.010805691,0.01635538,0.001054961,0.0005910023,0.011118778,0.00025267512,0.09730363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999881,0.000030238523,0.0000056821705,0.000015500782,0.000034063352,0.000033389693],"domain_scores_gemma":[0.99990594,0.000013255362,0.000015998095,0.0000055627847,0.000011364901,0.000047889378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017747181,0.0003742381,0.0006285623,0.00035515986,0.00029320145,0.000534841,0.00048452013,0.0010950164,0.008532512],"category_scores_gemma":[0.0002281468,0.00013762037,0.0005007297,0.000366024,0.00021749838,0.00030301444,0.00034099666,0.002295817,0.0033553855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008281127,0.0020004676,0.0022162267,0.003229262,0.0003612092,0.002898015,0.00015137694,0.00082785444,0.10313649,0.0034609365,0.09066765,0.78276944],"study_design_scores_gemma":[0.008850905,0.012411932,0.018057454,0.0018475493,0.0004031459,0.01788139,0.00016396026,0.0013381849,0.054242138,0.0018109302,0.8828755,0.000116887706],"about_ca_topic_score_codex":0.00072650553,"about_ca_topic_score_gemma":0.0019210789,"teacher_disagreement_score":0.008532512,"about_ca_system_score_codex":0.00030484077,"about_ca_system_score_gemma":0.00052262965,"threshold_uncertainty_score":0.028544128},"labels":[],"label_agreement":null},{"id":"W4200087363","doi":"10.1358/dot.2021.57.12.3352740","title":"Casimersen for Duchenne muscular dystrophy","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Medicine; Exon skipping; Duchenne muscular dystrophy; Dystrophin; Exon; Muscular dystrophy; Population; Antisense therapy; Bioinformatics; Clinical trial; Pharmacology; Internal medicine; Genetics; Gene; Oligonucleotide; Biology; Alternative splicing","score_opus":0.005900815163805081,"score_gpt":0.24271226631614984,"score_spread":0.23681145115234475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200087363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018491754,0.6208825,0.012374841,0.029546583,0.023275504,0.000905108,0.0019933458,0.0036382694,0.28889218],"genre_scores_gemma":[0.13176192,0.28565747,0.020715557,0.025846874,0.010054566,0.0020974088,0.004330075,0.00060853333,0.51892763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995932,0.00007984223,0.00003295192,0.00009921471,0.00013485146,0.000059839174],"domain_scores_gemma":[0.9995597,0.00008462917,0.000104339764,0.00003269888,0.000071441835,0.00014710084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007494143,0.0010492002,0.0006615291,0.001114029,0.000638939,0.0007730316,0.00057188555,0.0019267155,0.04131789],"category_scores_gemma":[0.000883963,0.00018773745,0.000527715,0.0005398389,0.00056799146,0.00065921334,0.00096432754,0.0022821692,0.026555141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012425389,0.0002687982,0.00029317135,0.0024156324,0.000080127335,0.0018060481,0.00011717178,0.0003085189,0.043157846,0.022986384,0.30633563,0.62098813],"study_design_scores_gemma":[0.00026187018,0.00043548807,0.00042368777,0.0002298569,0.000018145352,0.0024276606,0.00001031613,0.00008629208,0.005859119,0.0018264533,0.9884007,0.00002034287],"about_ca_topic_score_codex":0.00039588643,"about_ca_topic_score_gemma":0.0010146198,"teacher_disagreement_score":0.04131789,"about_ca_system_score_codex":0.0007460916,"about_ca_system_score_gemma":0.00091518904,"threshold_uncertainty_score":0.1382221},"labels":[],"label_agreement":null},{"id":"W4200565889","doi":"10.1358/dot.2021.57.12.3352760","title":"Delgocitinib in atopic dermatitis","year":2021,"lang":"en","type":"review","venue":"Drugs of today","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Tacrolimus; Calcineurin; Pimecrolimus; Janus kinase; Clinical trial; Dermatology; Safety profile; Ciclosporin; Pharmacology; Quality of life (healthcare); Pharmacokinetics; Janus kinase inhibitor; Adverse effect; Immunology; Transplantation; Internal medicine; Cytokine","score_opus":0.02845163800676103,"score_gpt":0.3400481662397611,"score_spread":0.31159652823300005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200565889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035548233,0.997785,0.000054478965,0.000115521194,0.0000984959,0.000006775114,0.000030786458,0.000007984763,0.0015455475],"genre_scores_gemma":[0.002612322,0.99585426,0.00012578981,0.00017188021,0.000083348794,0.0000075316784,0.000069730915,0.0000013449935,0.0010738805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999083,0.000014814166,0.000015441537,0.00001671164,0.000032896205,0.000011767597],"domain_scores_gemma":[0.99992144,0.00003678375,0.000016057618,0.0000019678941,0.000015798889,0.0000078346475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002325172,0.00043614022,0.00080475095,0.0015011737,0.00019601324,0.0006397789,0.00038281103,0.0005486604,0.0056442097],"category_scores_gemma":[0.00028994458,0.00013753826,0.000493197,0.0009913298,0.0001240102,0.00048025098,0.00036892327,0.00094396184,0.0016066381],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011266673,0.00006944069,0.0001342885,0.020080231,0.0001130748,0.00020162125,0.000033337205,0.00023470612,0.0016165429,0.0013146023,0.01827096,0.9578185],"study_design_scores_gemma":[0.00007262922,0.00016390692,0.0012595977,0.005644875,0.0003131181,0.0022580093,0.000041605676,0.000136891,0.00088570884,0.0008666382,0.98834175,0.0000152440325],"about_ca_topic_score_codex":0.0007025743,"about_ca_topic_score_gemma":0.0019919171,"teacher_disagreement_score":0.0056442097,"about_ca_system_score_codex":0.00030866338,"about_ca_system_score_gemma":0.0004771347,"threshold_uncertainty_score":0.018881738},"labels":[],"label_agreement":null},{"id":"W4210789185","doi":"10.1358/dot.2022.58.1.3353167","title":"Estetrol and drospirenone: a novel oral contraceptive","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Drospirenone; Estrogen; Endocrine system; Estrogen receptor; Endometrial cancer; Agonist; Pharmacology; Endometrium; Internal medicine; Endocrinology; Gynecology; Physiology; Receptor; Cancer; Hormone; Breast cancer","score_opus":0.014209523293942594,"score_gpt":0.27995647232749604,"score_spread":0.26574694903355345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210789185","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03900099,0.90949816,0.004973264,0.0040361024,0.0016578456,0.00015526761,0.00055842556,0.000247557,0.039872352],"genre_scores_gemma":[0.22574425,0.7119532,0.009122063,0.00486556,0.0031094654,0.00021794533,0.0011407186,0.000029444765,0.04381732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999237,0.0000133119975,0.00000695722,0.000016600894,0.000028762226,0.000010691666],"domain_scores_gemma":[0.99997175,0.0000045873617,0.0000074033824,0.0000015148821,0.000005041778,0.000009700245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001357822,0.0003312123,0.0002500866,0.0006047964,0.00017020834,0.0003337904,0.00024309699,0.00047035652,0.0035247062],"category_scores_gemma":[0.00016071904,0.00011841047,0.00025856987,0.00023807932,0.00020112169,0.00031433185,0.00024991998,0.0007035838,0.0013328146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006915346,0.00036072277,0.0010287047,0.001958203,0.0000975936,0.0028729856,0.00009249604,0.00033413142,0.066725254,0.008320719,0.022288121,0.8952296],"study_design_scores_gemma":[0.00040730566,0.0017365154,0.0028494445,0.00030981514,0.0000944317,0.0128390435,0.000045105204,0.00057234743,0.019814817,0.0016419429,0.9596364,0.000052824886],"about_ca_topic_score_codex":0.00025401177,"about_ca_topic_score_gemma":0.00058731064,"teacher_disagreement_score":0.0035247062,"about_ca_system_score_codex":0.00012628658,"about_ca_system_score_gemma":0.00014186013,"threshold_uncertainty_score":0.011791348},"labels":[],"label_agreement":null},{"id":"W4212843950","doi":"10.1358/dot.2022.58.2.3367993","title":"Loteprednol etabonate: a formulation for short-term use in inflammatory flares in dry eye disease","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Corticosteroid; Pharmacokinetics; Ophthalmology; Pharmacology; Internal medicine","score_opus":0.014644914344653344,"score_gpt":0.26912812639385025,"score_spread":0.2544832120491969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212843950","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78638834,0.17768441,0.016040094,0.0027912406,0.0012810682,0.0011430162,0.00119809,0.0009229779,0.012550873],"genre_scores_gemma":[0.9436015,0.028278422,0.014105039,0.00092856784,0.00030930585,0.0004067298,0.0009904752,0.000088695226,0.011291286],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988925,0.000020333477,0.0000120064,0.000017865546,0.000045104047,0.000015389642],"domain_scores_gemma":[0.99990845,0.000014501834,0.000026984795,0.0000049877067,0.000014392534,0.000030647963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024621407,0.00022894242,0.00025314477,0.0004280307,0.00024657795,0.00032403183,0.00030826547,0.000685458,0.0022640636],"category_scores_gemma":[0.00024035922,0.000105378305,0.00032482084,0.0001914742,0.00019720061,0.00045376926,0.00026745783,0.0007948478,0.0008201153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037611919,0.0009185273,0.0005978998,0.0014529602,0.000054576136,0.001083576,0.00013513083,0.0001941126,0.69888216,0.000714036,0.004572154,0.28763366],"study_design_scores_gemma":[0.0068433904,0.030893594,0.028984897,0.0004179552,0.00030274742,0.020344123,0.0001895237,0.003710156,0.59374,0.0005758262,0.31386116,0.0001366539],"about_ca_topic_score_codex":0.00056863093,"about_ca_topic_score_gemma":0.0012134712,"teacher_disagreement_score":0.0022640636,"about_ca_system_score_codex":0.00030403477,"about_ca_system_score_gemma":0.00022970988,"threshold_uncertainty_score":0.007574022},"labels":[],"label_agreement":null},{"id":"W4237872600","doi":"10.1358/dot.2017.53.1.2604171","title":"Notable deals in the pharmaceutical industry in the fourth quarterof 2016","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.027553480783548294,"score_gpt":0.33860766792118985,"score_spread":0.31105418713764155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237872600","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2515343,0.07639532,0.0027940087,0.037054885,0.014636613,0.0003126688,0.003941165,0.00069234235,0.6126387],"genre_scores_gemma":[0.44014555,0.03437061,0.0025597338,0.0070869895,0.005975315,0.000108439766,0.0047705015,0.00024163531,0.50474125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971609,0.00022098474,0.0001150976,0.00016724449,0.0018269952,0.0005087302],"domain_scores_gemma":[0.99655235,0.0004414128,0.0007890458,0.00015512625,0.0010859773,0.00097610493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027795434,0.000511015,0.00034421566,0.0022175014,0.001942537,0.008816687,0.0005281229,0.0015398301,0.016176207],"category_scores_gemma":[0.004668815,0.00029075125,0.00044842498,0.003271152,0.001082011,0.002553474,0.0025552402,0.001679625,0.0050795865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076819025,0.00027688523,0.030557245,0.0011504007,0.000060640068,0.0025172476,0.0041431845,0.0005757371,0.011494995,0.06864783,0.36560655,0.5142012],"study_design_scores_gemma":[0.000011323804,0.000093793926,0.027242415,0.00016627631,0.0000101778405,0.0005798277,0.0009517356,0.00017287773,0.002159676,0.001130238,0.96746093,0.000020843421],"about_ca_topic_score_codex":0.0032085867,"about_ca_topic_score_gemma":0.0072771455,"teacher_disagreement_score":0.016176207,"about_ca_system_score_codex":0.004289837,"about_ca_system_score_gemma":0.0028367958,"threshold_uncertainty_score":0.05411476},"labels":[],"label_agreement":null},{"id":"W4246551118","doi":"10.1358/dot.2015.051.06.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20, 2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Association (psychology); Psychiatry; Family medicine; Environmental health","score_opus":0.006765480933943373,"score_gpt":0.26065377439794957,"score_spread":0.2538882934640062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246551118","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009185758,0.04878299,0.0011880074,0.11614835,0.113656685,0.0009883658,0.021011924,0.0011160148,0.68792194],"genre_scores_gemma":[0.008452018,0.014855902,0.0008236067,0.0052746353,0.0043047485,0.000114772054,0.0066403975,0.00012898816,0.9594048],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990395,0.000060447503,0.000042949134,0.00006394998,0.00043515975,0.0003578987],"domain_scores_gemma":[0.99617934,0.000066402376,0.00008305967,0.00004721575,0.0022568628,0.001367148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015468767,0.0010849392,0.00088326295,0.0013088998,0.0033686403,0.0027521977,0.0011219376,0.0030892512,0.2676264],"category_scores_gemma":[0.0018006226,0.00051449984,0.0007417716,0.0009830559,0.00059946673,0.000832839,0.0018251879,0.00280116,0.12088102],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005333298,0.000025756324,0.000646856,0.000058089838,0.000007922335,0.000037841834,0.000011033079,0.000023427188,0.000106657164,0.00008341897,0.9796808,0.019264897],"study_design_scores_gemma":[0.00004412621,0.00005294539,0.018732963,0.00036074885,0.000020104428,0.00011890172,0.00016641119,0.00008019562,0.00011276343,0.00012982692,0.98016375,0.000017244907],"about_ca_topic_score_codex":0.35124236,"about_ca_topic_score_gemma":0.81164724,"teacher_disagreement_score":0.64875764,"about_ca_system_score_codex":0.0070202667,"about_ca_system_score_gemma":0.019162647,"threshold_uncertainty_score":0.8952995},"labels":[],"label_agreement":null},{"id":"W4247070633","doi":"10.1358/dot.2016.52.8.2540100","title":"Notable deals in the pharmaceutical industry in the first quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.028297717841431168,"score_gpt":0.28253825327545823,"score_spread":0.2542405354340271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247070633","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4380281,0.060882255,0.0014250659,0.026593069,0.0050796056,0.00018629333,0.0051776436,0.0004403931,0.4621875],"genre_scores_gemma":[0.71867925,0.029948335,0.001651339,0.0029981786,0.0031516522,0.000058391433,0.0054892087,0.00012476063,0.2378989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976179,0.0001563448,0.00011674283,0.00015951176,0.001549546,0.00039978718],"domain_scores_gemma":[0.9967444,0.0004032574,0.0011262017,0.00013435025,0.0008286655,0.0007631193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021019601,0.0003980637,0.00029736164,0.002708048,0.0019167509,0.008144311,0.000445305,0.0011540514,0.008775661],"category_scores_gemma":[0.004573239,0.00026962874,0.0003105057,0.0051112724,0.0009594049,0.0024716377,0.0023808097,0.0014552535,0.0026784865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007106088,0.00024179507,0.09264498,0.0010896536,0.00006987627,0.0027195811,0.008346279,0.0006999592,0.00750598,0.07781363,0.2573231,0.55083454],"study_design_scores_gemma":[0.000012414867,0.00012130047,0.12755193,0.0002487045,0.000017984492,0.00090975885,0.0027705068,0.00033040505,0.0027134195,0.0016330262,0.86365676,0.000033774802],"about_ca_topic_score_codex":0.0061138473,"about_ca_topic_score_gemma":0.013848585,"teacher_disagreement_score":0.008775661,"about_ca_system_score_codex":0.004342576,"about_ca_system_score_gemma":0.0021483246,"threshold_uncertainty_score":0.03150773},"labels":[],"label_agreement":null},{"id":"W4247809272","doi":"10.1358/dot.2018.54.2.2792548","title":"Life sciences licensing deals in the fourthquarter of 2017: updatesand trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Finance; Business","score_opus":0.10230217279665785,"score_gpt":0.4182660856357171,"score_spread":0.3159639128390592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247809272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3302822,0.20117642,0.002891734,0.072313085,0.010018925,0.00022281504,0.11305423,0.0017032928,0.26833734],"genre_scores_gemma":[0.44224373,0.20739922,0.0034095943,0.012762041,0.011275201,0.00025789445,0.14099863,0.00091674435,0.18073697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958759,0.00021977896,0.00041344992,0.000378364,0.0025891636,0.0005233609],"domain_scores_gemma":[0.9718919,0.004161003,0.010488151,0.00044966696,0.010595278,0.002414027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027253118,0.0005840403,0.00053004606,0.009814162,0.00059645384,0.006647993,0.00092366803,0.0013259047,0.020480216],"category_scores_gemma":[0.014580016,0.00037887186,0.0006719089,0.01701852,0.00073267997,0.0068963426,0.0018863011,0.0022101146,0.008855257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040815448,0.00024416007,0.15818106,0.0013832123,0.00008813442,0.00028937572,0.000994163,0.00040167107,0.00066034094,0.006143018,0.419851,0.41135582],"study_design_scores_gemma":[0.000024908895,0.000083826075,0.17760395,0.0007051338,0.000052395422,0.0005359272,0.0015320863,0.00037250615,0.0011486374,0.000497526,0.8174078,0.00003538972],"about_ca_topic_score_codex":0.02436824,"about_ca_topic_score_gemma":0.028766122,"teacher_disagreement_score":0.02436824,"about_ca_system_score_codex":0.004014987,"about_ca_system_score_gemma":0.0042465725,"threshold_uncertainty_score":0.068513155},"labels":[],"label_agreement":null},{"id":"W4252160329","doi":"10.1358/dot.2017.53.10.2746403","title":"Notable licensing deals in the biopharma industry in the thirdquarter of 2017","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Pharmaceutical industry; Pharmacology; Finance; Business","score_opus":0.0631181787243877,"score_gpt":0.3970966101145358,"score_spread":0.3339784313901481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252160329","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10687447,0.012185462,0.0019362731,0.037186008,0.010631972,0.0004322002,0.0069838045,0.0020942944,0.8216756],"genre_scores_gemma":[0.24720533,0.006788512,0.00091439136,0.010309414,0.006407634,0.0002099559,0.008159922,0.000557171,0.7194476],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951237,0.00021338767,0.00011672213,0.00038435668,0.003366522,0.00079526595],"domain_scores_gemma":[0.9886003,0.0019777461,0.0020083787,0.00055855885,0.0034413862,0.0034135487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003109836,0.0005927868,0.0003418915,0.0035915475,0.0025582549,0.008109556,0.00077274657,0.0020792335,0.042754292],"category_scores_gemma":[0.008317816,0.0004209294,0.00063659786,0.0035801681,0.0015334958,0.0027626231,0.0032609007,0.0033644966,0.016118936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004197984,0.00016699095,0.021802474,0.0003648893,0.000041415904,0.0015851541,0.0011441095,0.00017608583,0.0048959847,0.029080376,0.821357,0.11896562],"study_design_scores_gemma":[0.00003375286,0.0001081746,0.04008614,0.00011329824,0.00001117658,0.00053001265,0.00070045487,0.00017397474,0.0026237066,0.00091322826,0.9546787,0.000027447162],"about_ca_topic_score_codex":0.012605521,"about_ca_topic_score_gemma":0.02195854,"teacher_disagreement_score":0.042754292,"about_ca_system_score_codex":0.0053096456,"about_ca_system_score_gemma":0.0063863113,"threshold_uncertainty_score":0.14302737},"labels":[],"label_agreement":null},{"id":"W4253026915","doi":"10.1358/dot.2003.39.4.799404","title":"Aminoglycoside ototoxicity","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Aminoglycoside; Ototoxicity; Medicine; Pharmacology; Toxicity; Antibiotics; Gentamicin; Hearing loss; Internal medicine; Genetics; Biology; Audiology; Chemotherapy","score_opus":0.09214801784366826,"score_gpt":0.3536444778535877,"score_spread":0.26149646000991944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253026915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021514347,0.9975701,0.00014011395,0.00017615386,0.00018075718,0.0000041119615,0.000013429756,0.000014609455,0.0016855028],"genre_scores_gemma":[0.0015057585,0.99698704,0.0001409677,0.00017843166,0.00021993836,0.0000044370677,0.00002766814,0.0000019090578,0.00093397754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997235,0.000034207493,0.00005148186,0.00005069913,0.00011353549,0.000026499329],"domain_scores_gemma":[0.9996283,0.00013417528,0.000072449744,0.000015314596,0.00011233741,0.000037329337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034361583,0.0015021841,0.0019806705,0.0026232942,0.00042705605,0.00093775714,0.0007730198,0.0013084917,0.0041053356],"category_scores_gemma":[0.00063522,0.00020128436,0.00045861857,0.0019840403,0.0005682086,0.0010883684,0.00068612956,0.0011834042,0.003406813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054127966,0.000059148104,0.0004493929,0.009075974,0.000060078117,0.0011726541,0.000046681962,0.00019055624,0.0016095558,0.00082484854,0.022751918,0.963705],"study_design_scores_gemma":[0.000027068825,0.00013242669,0.0028394319,0.003731683,0.00015324423,0.024083013,0.000137521,0.00012982496,0.0015914263,0.0021618828,0.96498626,0.000026316371],"about_ca_topic_score_codex":0.0011597621,"about_ca_topic_score_gemma":0.0021378784,"teacher_disagreement_score":0.0041053356,"about_ca_system_score_codex":0.00063780125,"about_ca_system_score_gemma":0.0008132771,"threshold_uncertainty_score":0.013733685},"labels":[],"label_agreement":null},{"id":"W4253652799","doi":"10.1358/dot.2011.47.10.1656503","title":"Boceprevir","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boceprevir; Medicine; Ribavirin; Pharmacology; Hepatitis C virus; Telaprevir; Virology; Internal medicine; Virus","score_opus":0.12138981915520225,"score_gpt":0.41693319128266637,"score_spread":0.2955433721274641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253652799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007755538,0.9893421,0.00047819028,0.00043547322,0.00044509815,0.000040741485,0.0002137698,0.00008283369,0.008186249],"genre_scores_gemma":[0.009497752,0.9774185,0.0013105822,0.001191731,0.0003006225,0.000056181852,0.00073452806,0.000013571552,0.009476671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998516,0.000028133978,0.000016990818,0.00003148534,0.000050750907,0.000020989346],"domain_scores_gemma":[0.99993193,0.00001986868,0.000016330661,0.0000031062152,0.00001664158,0.000012110413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027413954,0.0008290266,0.00090498116,0.0012918138,0.00022294163,0.0005462739,0.00074343366,0.00076350366,0.0091160275],"category_scores_gemma":[0.00031305873,0.00018648448,0.0005300124,0.00089433946,0.0001856154,0.00053008547,0.00036040568,0.0014938172,0.0076149055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003030632,0.00009084537,0.00010521347,0.006490396,0.00009957271,0.00029224964,0.000028364175,0.00016756113,0.0029278817,0.0016602187,0.04552593,0.94230866],"study_design_scores_gemma":[0.00017351554,0.00016793021,0.0008140378,0.0011586195,0.000096396594,0.0023070793,0.000015505957,0.00007130686,0.0013898654,0.00059255783,0.9931961,0.000017098328],"about_ca_topic_score_codex":0.0013171473,"about_ca_topic_score_gemma":0.0023023535,"teacher_disagreement_score":0.0091160275,"about_ca_system_score_codex":0.0004683551,"about_ca_system_score_gemma":0.00038465494,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4253960987","doi":"10.1358/dot.2016.52.10.2560079","title":"Notable deals in the pharmaceutical industry in the third quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.01796769573493584,"score_gpt":0.30438071112821696,"score_spread":0.2864130153932811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253960987","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51466197,0.04439362,0.0016931671,0.018283835,0.0039971457,0.00022826943,0.0057711727,0.00045836065,0.4105125],"genre_scores_gemma":[0.72324264,0.025782075,0.001534956,0.0033619022,0.0030395377,0.00008336331,0.006334856,0.00015386238,0.23646684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977069,0.00013645673,0.00010564941,0.00014377008,0.0015425566,0.0003647003],"domain_scores_gemma":[0.99667966,0.00044873147,0.0012406852,0.00014378733,0.00077587063,0.00071132433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021340835,0.00039333946,0.00027560606,0.0025617185,0.0014381505,0.006718626,0.0003964015,0.0011244795,0.008789172],"category_scores_gemma":[0.0044815377,0.00024997693,0.00042569824,0.0039609773,0.0008633228,0.0021506862,0.0020665368,0.0012948551,0.0031326087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079989503,0.00028616522,0.13158588,0.0011102038,0.00009917562,0.0035698048,0.007171768,0.000795523,0.014628869,0.067335196,0.25285918,0.5197584],"study_design_scores_gemma":[0.000017648073,0.00014196707,0.17502643,0.00026318798,0.00002217103,0.0015887183,0.002259545,0.00043348642,0.0043902267,0.001465596,0.81435335,0.000037667858],"about_ca_topic_score_codex":0.0039755404,"about_ca_topic_score_gemma":0.008535238,"teacher_disagreement_score":0.008789172,"about_ca_system_score_codex":0.003127889,"about_ca_system_score_gemma":0.0018818473,"threshold_uncertainty_score":0.029402733},"labels":[],"label_agreement":null},{"id":"W4282918298","doi":"10.1358/dot.2022.58.6.3400572","title":"Bimekizumab for psoriasis","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Psoriasis; Ustekinumab; Tolerability; Adalimumab; Adverse effect; Dermatology; Immunology; Immune system; Population; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis","score_opus":0.01460619210585043,"score_gpt":0.24055590479578004,"score_spread":0.2259497126899296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282918298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015575104,0.7783365,0.0043329583,0.042613477,0.016481165,0.0003141126,0.0006732831,0.00095428,0.14071923],"genre_scores_gemma":[0.16436774,0.45178565,0.010240351,0.07384626,0.027098686,0.00041017964,0.002330655,0.0002470391,0.26967338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998192,0.00003093687,0.000014302822,0.000028177747,0.00006953923,0.000037863534],"domain_scores_gemma":[0.99985325,0.000022816417,0.000024008443,0.000008268234,0.000027847811,0.00006377675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004047719,0.00043886396,0.00042660703,0.00044132676,0.00034948642,0.00053126906,0.00030948283,0.0010486735,0.02028631],"category_scores_gemma":[0.00051054376,0.000077171564,0.0005009832,0.00024344421,0.00017295308,0.00044987837,0.0005087388,0.0021007722,0.0111667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005331149,0.0002915748,0.00041183236,0.0008887532,0.00005135854,0.00084231613,0.00003920682,0.00011531431,0.004936821,0.003880175,0.17710589,0.81090367],"study_design_scores_gemma":[0.0005665844,0.00061144185,0.0010925785,0.00045630653,0.000041774303,0.0049124295,0.000016747443,0.00016842256,0.0015136168,0.0027935004,0.9878154,0.000011321528],"about_ca_topic_score_codex":0.00017954852,"about_ca_topic_score_gemma":0.0004504085,"teacher_disagreement_score":0.02028631,"about_ca_system_score_codex":0.00039841945,"about_ca_system_score_gemma":0.00045021705,"threshold_uncertainty_score":0.06786448},"labels":[],"label_agreement":null},{"id":"W4294577824","doi":"10.1358/dot.2022.58.9.3422313","title":"Efficacy of vosoritide in the treatment of achondroplasia","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Achondroplasia; Medicine; Endocrinology; Natriuretic peptide; Internal medicine; Dwarfism; Mutation; NPR2; Fibroblast growth factor receptor 3; Guanosine; Mutant; Receptor; Genetics; Fibroblast growth factor; Gene; Biology; Surgery","score_opus":0.013059932695318027,"score_gpt":0.2960372429706298,"score_spread":0.28297731027531176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294577824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90830714,0.07710364,0.00097316765,0.0007290413,0.00031930918,0.00019752707,0.0003562177,0.00020641086,0.011807609],"genre_scores_gemma":[0.9828728,0.01246977,0.00076499017,0.00024226317,0.00009296106,0.000047725916,0.0002798945,0.000014265547,0.0032153535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989355,0.0000312695,0.000009623288,0.000014501921,0.000029331673,0.000021685773],"domain_scores_gemma":[0.99987876,0.000032720425,0.000018942059,0.000006242825,0.00001791569,0.0000454321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020875764,0.00022199728,0.00042494014,0.00032459458,0.00013026316,0.00019389878,0.00024289032,0.00041577488,0.0014661414],"category_scores_gemma":[0.00032280653,0.00005583826,0.0003808574,0.00016088234,0.00012106787,0.00016482717,0.0001268969,0.0006011302,0.0002507226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053631417,0.008687007,0.0061775423,0.002617585,0.0009221969,0.0017175254,0.00018724216,0.001237604,0.2565854,0.0009970475,0.0027644176,0.664475],"study_design_scores_gemma":[0.039558027,0.27704722,0.22402513,0.0015889436,0.002409081,0.011388277,0.00062348286,0.0054591717,0.28861895,0.0012319164,0.14792164,0.00012814369],"about_ca_topic_score_codex":0.0008450042,"about_ca_topic_score_gemma":0.0011715457,"teacher_disagreement_score":0.0014661414,"about_ca_system_score_codex":0.00017399299,"about_ca_system_score_gemma":0.00020444374,"threshold_uncertainty_score":0.0049048066},"labels":[],"label_agreement":null},{"id":"W4322495836","doi":"10.1358/dot.2023.59.3.3521858","title":"Cenegermin for the treatment of dry eye disease","year":2023,"lang":"en","type":"review","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Tropomyosin receptor kinase A; Nerve growth factor; Clinical trial; Disease; Authorization; Intensive care medicine; Ophthalmology; Internal medicine; Receptor","score_opus":0.05328641506398813,"score_gpt":0.3666833527670074,"score_spread":0.3133969377030193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322495836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026564253,0.9977666,0.0001036178,0.00014320723,0.00017641622,0.000010713923,0.000035725916,0.000010985353,0.0014871001],"genre_scores_gemma":[0.002144838,0.9957825,0.0002543879,0.00025297143,0.00009961746,0.000013585669,0.00007791499,0.0000030865976,0.0013711875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985147,0.000028112465,0.000024187173,0.000025070669,0.000056094916,0.000015045151],"domain_scores_gemma":[0.999892,0.000050738443,0.00001966783,0.0000035310968,0.000023359624,0.000010676115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032499927,0.0006153818,0.0009638756,0.002163946,0.00022479391,0.0007008056,0.0005967313,0.0007441548,0.006607501],"category_scores_gemma":[0.00042888068,0.00015890917,0.0006526094,0.001113803,0.0002448761,0.0005598635,0.00044379532,0.0015506264,0.0024295824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013401416,0.00009716924,0.00010552693,0.02048471,0.0001535724,0.00021636082,0.00005021804,0.00019446632,0.002489182,0.0018607905,0.01981132,0.9544027],"study_design_scores_gemma":[0.00007641288,0.0001615245,0.0009766489,0.0046216943,0.00021826665,0.0016632723,0.000043282354,0.0000769426,0.0008657661,0.00090892246,0.99037105,0.000016263437],"about_ca_topic_score_codex":0.00093885005,"about_ca_topic_score_gemma":0.002148744,"teacher_disagreement_score":0.006607501,"about_ca_system_score_codex":0.00033529193,"about_ca_system_score_gemma":0.0005081565,"threshold_uncertainty_score":0.022104323},"labels":[],"label_agreement":null}]}